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Abstract 
The liver is the organ, which is most frequently populated by metastases and may 
therefore serve as a model organ for metastatic invasion. For this reason, it was the 
aim of this thesis to understand the gene expression profiles and identify metastasis 
and invasion related genes.  
Differential gene expression was examined in three systems: A syngeneic mouse 
model (CT26/Balb/C mouse), a xenograft model (LS174/nude mouse) and five 
clinical specimens.  
Gene expression profiles of a syngenic mouse model (CT26) and human clinical 
specimen revealed that the invasion front should be considered as a whole instead of 
separating it into histologically defined liver invasion and tumor invasion to find more 
overlapping potential target genes. This indicates that gene expression patterning 
may aid in the assessment of the suitability of an animal model for target gene 
determination.  
Global gene expression studies focussed on the host part of the invasion front, using 
gene ontology terms and GOSSIP software revealed a pronounced 
overrepresentation of GO-terms (e.g. “extracellular matrix”, “cell communication”, 
“response to biotic stimulus”, “structural molecule activity” and “cell growth”). On the 
single gene level hepatic stellate cell (HSC) activation markers were over-
represented in this region demonstrating the feasibility of a differential gene 
expression approach on a genome wide scale. 
Global gene expression studies focusing on the tumor cells in vitro, in vivo and tumor 
part of the invasion front revealed an overall increase of cellular specialization from in 
vitro to the in vivo situation and a further increase of specialization from tumor to 
invasion front. Secreted angiogenic cytokines (Invasion specific pattern) were found 
to be up regulated in the invasion front compared to the inner parts of the tumor. ß -
catenin gene of “cell adhesion” GO term was elevated 9.6 fold in invasion front 
compared to in vitro. Evaluation of transcriptional up-regulation of ß-catenin by 
promoter activity showed an 18.4 fold increase in the tumor cells of the invasion front 
as compared to the tumor cells in the inner parts of the tumor. In addition, promoter 
activity as assessed by soluble human placental alkaline phosphatase reporter gene 
mRNA was 3.5 fold higher in the inner parts of the tumor than in cells growing in cell 
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culture indicating a transcriptional mechanism of β-catenin regulation in addition to 
the well described posttranslational regulatory mechanisms.  
In summary, application of high throughput Oligonucleotide microarray analysis in 
combination with real time PCR technology allowed the identification of genes, which 
might play a role in proliferation, invasion and angiogenesis of tumors in colorectal 
liver metastasis.  
Key words 
Tumor-stromal cell interactions, invasion and metastasis, gene expression profiling, 
xenograft models, liver, β-catenin, cross-species. 
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Zusammenfassung 
Die Leber ist das am häufigsten von Metastasen betroffene Organ und kann daher 
als Modellorgan für metastatische Invasion dienen. Aus diesem Grund war es das 
Ziel dieser Dissertation Genexpressionsprofile zu verstehen und metastasierungs- 
sowie invasionsassoziierte Gene zu identifizieren. 
Differentielle Genexpression wurde in drei Systemen überprüft: Einem syngenen 
Mausmodell (CT26/Balb/C Maus, einem Xenograftmodell (LS 174/Nacktmaus) sowie 
in fünf Gewebeproben von Patienten. 
Genexpressionprofile des syngenen Mausmodells (CT26) und der Patientenproben 
zeigten, dass man die Invasionsfront als Ganzes betrachten sollte und sie nicht in 
einen histologisch naheliegenden Leberteil und Tumorteil separieren sollte, um 
möglichst viele überlappende Gene zu finden. Diese Daten zeigen, dass die 
Ermittlung von Genexpressionsmustern bei der Prüfung der Eignung eines 
Tiermodells für die Ermittlung von Targetgenen helfen kann. 
Globale Genexpressionstudien, die auf den Wirtsteil der Invasionsfront fokussiert 
sind zeigten bei Nutzung von „gene ontology terms“ und der „Gossip“ Software eine 
bemerkenswerte Überrepräsentation z. B. der „GO-terms“ „extrazelluläre Matrix“, 
Zellkommunikation“, „Antwort auf biotischen Stimulus“, Strukturmolekülaktivität“ und 
„Zellwachstum“. Auf der Einzelgenebene waren in dieser Region Marker der 
Aktivierung hepatischer Sternzellen (HSCs) überrepräsentiert, was die 
Durchführbarkeit einer Analyse differentieller Genexpression im genomweiten 
Rahmen anzeigt.  
Globale Genexpressionsstudien, mit Fokus auf den Tumorzellen in der in vitro 
Situation, in vivo und in der Invasionsfront zeigten insgesamt einen Anstieg zellulärer 
Spezialisierung von der in vitro- zur in vivo Situation und einen weiteren Anstieg vom 
Tumorinneren zur Invasionsfront. Sezernierte proangiogenetische Chemokine 
(invasionsspezifisches Muster) zeigten eine Hochregulation in der Invasionsfront im 
Vergleich zum Tumorinneren. Das β-catenin -Gen (GO-term „cell adhesion“) war in 
der Invasionsfront 9.6 fach erhöht im Vergleich zur in vitro Situation. Die Überprüfung 
der transkriptionellen Aktivierung von β-catenin über die Prüfung der 
Promotoraktivität zeigte einen 18.4 fachen Anstieg in den Tumorzellen der 
Invasionsfront verglichen mit den Tumorzellen im Tumorinneren. Weiterhin war die 
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Promotoraktivität (an Hand der Aktivität der mRNA des Alkalischen Phosphatase 
Reportergens) im Tumorinneren 3.5 fach höher als in der Zellkultur, was für einen 
transkriptionellen Mechanismus der β-catenin Regulation zusätzlich zu den bereits 
gut beschriebenen posttranslationalen Mechanismen spricht. 
Zusammenfassend kann man festhalten, dass die Hochdurchsatz-Oligonukleotid 
Mikroarray-Analyse in Kombination mit der real time PCR Technologie die 
Identifikation von Genen ermöglicht hat, die eine Rolle in Proliferation, Invasion und 
Angiogenese in kolorektalen Lebermetastasen spielen könnten.  
 
Schlagworte 
Tumor-stroma Zelle interaktionen, Invasion und Metastasierung, Gene Expression 
Profiling, genograft modelle, leber, β-catenin, Inter-spezies 
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1 Introduction 
1.1 Epidemiology of colon cancer 
Colorectal cancer, also called colon cancer or bowel cancer, includes cancerous 
growths in the colon, rectum and appendix. It is the third most common form of 
cancer and the second leading cause of death among cancers in the Western world. 
Many colorectal cancers are thought to arise from adenomatous polyps in the colon. 
These mushroom-like growths are usually benign, but some may develop into cancer 
over time. The majority of the time, the diagnosis of localized colon cancer is through 
colonoscopy. The most common colon cancer cell type is adenocarcinoma which 
accounts for 95% of cases. Other, rarer types include lymphoma and squamous cell 
carcinoma.Colon cancer incidence is not much different between males and females, 
however colon cancer is slightly more prevalent in women compared to men (ratio of 
1.2:1) but the rectal cancer is more common in males (ratio of 1.7:1). Colon cancer is 
more common among elderly persons compared to younger persons. The risk of 
developing colon cancer begins to increase from the age of 40 and goes up with 
every passing year. The median age of presentation of colon cancer varies according 
to the country. In the United States the median age at presentation is 72 years. Colon 
cancer is more common in African Americans compared to the Caucasian population 
in the United States. The incidence of colon cancer has been on the increase in 
African Americans since 1973 and the incidence in this ethnic group has gone up by 
about 30 percent during the last 3 decades.  Incidence of colorectal cancer varies 
widely from country to country. Countries which are more industrialized like United 
States, Canada, UK, Western Europe, Australia have a much higher incidence of 
colorectal cancer compared to less industrialized parts of the world like Asia, Africa, 
and South America. The American Cancer Society estimates that about 145,000 
cases of colorectal cancer will be diagnosed and about 56,000 people will die from 
the disease in 2005. The death rate from colon cancer has declined over the past 15 
years due to improved screening methods and advances in treatment. 
1.2 Etiology of colon caner  
Age is the primary risk factor. Incidence of the disease increases significantly after 
the age of 50. Some people have a genetic predisposition to carcinogenic (i.e., 
cancer causing) effects of the diet on the digestive tract, which increases the risk for 
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colorectal cancer. When this predisposition is combined with a high dietary intake of 
fat and red meat and a low dietary intake of fiber (e.g., bran), vitamins (e.g., folate), 
and minerals (e.g., calcium), the risk is even higher. Ashkenazi Jews have a higher 
incidence of a specific genetic mutation (called I1307K) that increases the risk for 
colorectal cancer. Daily alcohol use (may double the risk), eating a high-fat, low-fiber 
diet, obesity, sedentary lifestyle, Smoking. A family history of intestinal polyps or 
colorectal cancer (especially before the age of 60) results in an increased risk for the 
disease. Other diseases and medical conditions that increase the risk include 
diabetes, genetic disorders such as familial polyposis syndromes and hereditary non-
polyposis colon cancer syndrome (HNPCC), inflammatory bowel disease (e.g., 
ulcerative colitis, Crohn's colitis, granulomatous colitis). (Familial polyposis 
syndromes are rare genetic (i.e., inherited) conditions characterized by early onset 
of multiple intestinal polyps (called polyposis) and a very high (virtually 100%) risk 
for colorectal cancer. Familial adenomatous polyposis (characterized by as many as 
thousands of polyps throughout the entire colon), Hereditary nonpolyposis colon 
cancer (HNPCC) syndrome is a genetic condition characterized by early-onset 
colorectal cancer (i.e., develops before age 50) and multiple colorectal cancers). 
 
1.3 Prognosis of colon caner 
Colorectal cancer can be asymptomatic (i.e., it may not cause symptoms). Blood in 
the stool is a common sign of the disease. Blood may be bright red or dark in color, 
and may not be noticeable. Chronic bleeding may result in iron deficiency anaemia, 
which may cause fatigue and pale skin. Other symptoms include: Abdominal 
discomfort (e.g., pain, bloating, cramping, fullness), change in bowel habits, 
Constipation or diarrhoea, narrow stools, nausea and vomiting, unexplained weight 
loss and hepatomegaly (enlargement of the liver) due to spreading of the tumor. The 
survival rate for people with colorectal cancer depends on the extent of the cancer at 
the time of diagnosis and the individual’s response to treatment. In addition, many 
new discoveries have the potential for improving the treatment of colorectal cancer, 
as well as the prognosis. Prognosis depends on the stage of the disease and the 
overall health of the patient. Overall, colorectal cancer patients have a 5-year survival 
rate of about 61%. The 5-year survival rate is about 92% when the disease is treated 
before it has spread (metastasized); 64% when the cancer has spread to nearby 
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organs or lymph nodes; and 7% when it has spread to other parts of the body (e.g., 
liver, lungs).  
 
1.4 Colorectal liver metastasis 
The liver is the most common site of distant metastasis from colorectal cancer for two 
main reasons.  
A. The liver filters the venous drainage from the intra-abdominal viscera, including the 
distal oesophagus, stomach, spleen, small bowel, colon, rectum, adrenals, pancreas, 
gallbladder, and biliary tree. Furthermore, the liver receives 30% of the cardiac 
output. Thus, the volume of blood filtered by the liver is second only to that filtered by 
the lungs.  
B. Physiologically, the liver is occupied by numerous cell types capable of providing a 
rich milieu for tumor cell growth. Tumor cells that survive the systemic circulation may 
eventually reach the liver. If the tumor cells express the appropriate phenotype 
allowing progression through all stages of the metastatic cascade, then the result is a 
metastasis. The liver microenvironment consists of not only organ- specific cells, 
such as hepatocytes, but also endothelial cells, pericytes, inflammatory cells, Kupffer 
cells, fibroblasts, and the extracellular matrix, all of which provide a favourable milieu 
for tumor cell implantation and initiation of angiogenesis. (Radinsky et al., 1996) 
 
1.5 Therapeutic approaches for colorectal liver metastasis  
Clinical experience suggests that patients with colorectal liver metastases have 
heterogenous tumor biology. The ongoing trend is to include a surgical approach for 
more patients with liver metastases from colorectal carcinoma. With the addition of 
newer chemotherapeutics, survival has improved in patients treated both medically 
and surgically for metastatic colorectal cancer. The role of neoadjuvant 
chemotherapy is being clarified. The current approach is upfront surgery unless a 
lesion is considered unresectable. Neoadjuvant therapy may soon be recommended 
more frequently, however, as more predictable responses from the intervention occur. 
During the preoperative evaluation, attention needs to be focused on considering 
sufficient liver parenchyma and assessment for extra hepatic disease. Survival 
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benefits in patients undergoing a second liver resection have similar outcomes as 
those undergoing a primary resection. Regardless of the surgical resection, patients 
benefit most when tumor-free margins greater than 1 cm are achieved. If the margins 
are close, RFA or cryotherapy can be added to ensure an adequate depth. Resection 
remains a critical treatment modality for patients with colorectal liver metastases 
since it provides the only significant chance for cure or long-term survival. With the 
extraordinary advances made in chemotherapeutics as well as newer surgical 
techniques, metastatic colon cancer remains a potentially curable disease. Patients 
are best treated in a multimodality environment where a medical oncologist, a 
radiologist, and those skilled in hepatobiliary surgery plan and execute optimal 
therapy. 
1.6 Physiopathology of Liver Metastasis 
Spreading of cancer cells from their site of origin to distant organs, named metastasis 
is a major cause of therapy failure (Mareel et al., 1993). In colorectal cancer half of 
the cancer deaths are due to loco-regional extension and the other half due to distant 
metastasis. In order to metastasise, cancer cells must acquire the capability to invade 
into the vascular system, to survive and to proliferate at the place of metastasis. 
Invasion marks the onset of malignancy; cells are released from their normal 
epithelial context, lose polarity, perforate the basement membrane and finally migrate 
into the stroma. There, they meet with the vessels that provide a route for transport to 
distant sites such as the liver. Then, metastases emerge through proliferation of 
cancer cells that have left the vessel and lodged in the liver parenchyma or have 
formed an embolus in the vessel lumen and grown from that site. All these activities 
are intimately linked with alterations of a variety of host cells that are in continuous 
cross talk with the cancer cells (Mareel et al., 1993). The liver is a frequent site of 
metastasis from many types of primary tumours (Debois et al., 2002). Such high 
frequency and liver specificity cannot be explained solely by the blood flow in the 
efferent vessels, portal vein and hepatic arteries respectively. 
 Organ specificity of metastasis, as exemplified by the liver, is best explained by the 
“seed” and “soil” hypothesis by Paget in 1889 (Paget 1889). He raised the question 
“What is it that decides what organ shall suffer in a case of disseminated cancer?”. 
His answer was “The microenvironment of each organ (the soil) influences the 
survival and growth of tumour cells (the seed)”. This hypothesis is still valid and 
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serves as a rich source of inspiration for clinical and experimental analysis of 
metastasis. What modern research has added to Paget’s seed and soil hypothesis 
mainly concerns the cellular and molecular mechanisms that underpin the cross talk 
between the cancer cells and their host.   
A current definition of the "seed and soil" hypothesis consists of three principles. 
First, neoplasms are biologically heterogeneous and contain subpopulations of cells 
with different angiogenic, invasive, and metastatic properties. Second, although some 
of the steps in this process contain stochastic elements, metastasis as a whole favors 
the survival and growth of a few subpopulations of cells that pre-exist within the 
parent neoplasm. Thus, metastases can have a clonal origin, and different 
metastases can originate from the proliferation of different single cells. Third, the 
outcome of metastasis depends on multiple interactions ("cross talk") of metastatic 
cells with homeostatic mechanisms.  
The cancer cells are the seed 
Before cancer cells produce metastases, they undergo a series of genetic alterations, 
conveying upon them uncontrolled growth, loss of differentiation, acquisition of 
invasion and ectopic survival (Mareel et al., 2002).  
The liver is the soil 
1.6.1 The role of the host in metastasis 
Numerous clinical and experimental observations support the role of host factors in 
the development and the malignancy of tumours. Pathologists have since a long time 
recognized that tumours contain not only cancer cells but also host cells. This host 
participation is described as desmoplasia, consisting of fibroblastic cells and 
extracellular matrix, as inflammation and immune response, represented by 
lymphocytes, macrophages and dendritic cells, and as angiogenesis evidenced by 
newly formed blood and lymph vessels (Mareel et al., 2003). 
1.6.2 Specific growth or specific homing 
The question whether cancer cells can home everywhere and grow only at distinct 
sites or whether they home only at specific sites but can grow everywhere is too 
simple. Metastasis is a multifactorial event including molecular crosstalking between 
cancer cells and host cells as well as the blood flow, carrying colorectal cancer cells 
Introduction  
 12
to the capillary bed of the liver via the portal vein. Growth is currently best explained 
in terms of neoangiogenesis (Carmeleit et al., 2000). When the balance between 
positive and negative angiogenic factors switches to the positive side, endothelial 
cells are stimulated to leave the constraints of the vessel wall; much like invasive 
cancer cells leave the epithelium. These endothelial cells migrate towards the cancer 
cell nest, proliferate and finally differentiate to make new vessels. Such vessels 
constitute not only a source of nutrients, growth factors and invasion factors but also 
provide access for host cells from distant sites, initiate further spread of the cancer 
cells and establish a link between the primary tumour and its metastases (O´Reilly et 
al., 1994). Homing of cells implicates a stepwise interaction between the circulating 
cancer cells and the endothelium that is regulated by the cross talk of cell adhesion 
molecules and chemokines with their respective receptors. Two molecular 
explanations have been forwarded for specific homing: expression of specific 
receptors on the surface of endothelial cells or release of specific chemokines, 
molecules exerting an attractive force on circulating cancer cells that bear specific 
receptors. Such chemo-attractants have been demonstrated for breast cancer (Müller 
et al., 2001).  
 Metastasis is a hallmark of malignancy in cancers of the gastrointestinal tract. In 
colorectal cancers as well as in cancers of many other organs, the liver is a 
predilection site for metastasis. This predilection is explained by the seed and soil 
theory, launched by Paget in 1889 (Paget 1889). The seed, cancer cells, need a 
series of genomic alterations in oncogenes and tumour-suppressor genes to invade, 
survive and grow in distant organs. The soil, the liver, produces attractants and 
growth factors that undertake molecular cross talk with the metastatic cancer cells. 
Understanding of the mechanisms of metastasis may assist in the treatment. 
Besides unrestricted proliferation and reduced apoptosis, unbalanced invasion is the 
third major prerequisite of malignant behaviour of the tumor cell. Invasion of tumor 
cells depends on a permissive host environment at the invasive site of the primary 
tumor as well as at the site of metastasis. The host participates in the induction, 
selection and expansion of neoplastic cells to an extent that researchers are even 
raising the question of “who is invading whom?”(Liotta et al., 2001). Likewise, the 
tumor cells of the invasion front display features, which differ from those in the inner 
parts of the tumor.  The increased knowledge about this host environment and 
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possible therapeutic advantages of targeting this compartment like reduced capability 
to acquire resistance and easy access have led to the development of several 
therapeutics (Liotta et al., 2001). Prominent examples of this group of drugs are 
synthetic metalloprotease inhibitors, which have received much attention although 
only recently one trial proved clinical therapeutic efficacy (Bramhall et al., 2002& 
Evans et al., 2001). The difficulty in the design of stromal therapeutics may in part be 
due to the huge number of potential target molecules and the complicated not yet 
resolved interactive pathways. As an adjunct to focussed mechanistic studies which 
are usually performed in vitro, understanding of the biological processes could be 
increased by global in vivo gene expression studies. Several interesting studies 
towards this direction have been reported (Ryu et al., 2001,Roesch et al., 2003, 
Paweletz et al., 2001, Mariani et al., 2001& Brazma et al., 2001) but studies with a 
clear focus on the gene expression patterns of the host tissue excluding the 
tumorous epithelial compartment have not yet been published. 
 
1.7 Microarray technologies for global gene expression profiles and 
identification of invasion related genes 
Patterns in the invasion front as compared to the inner parts of the tumor have been 
published (Mariani et al., 2001, Roesch et al., 2003 & Iacobuzio-Donahue et al., 
2002). However, none has specifically focussed on angiogenesis or on liver 
metastases nor has there been a distinction between tumor genes and host genes. 
This distinction is of particular interest if tumor cell/host cell interaction which is the 
initiating and probably crucial interaction during angiogenesis is studied in vivo. 
In particular, the microenvironment has a significant effect on tumor development and 
progression (Bissell et al., 2001). Tumor cell lines have been considered an important 
resource for cancer investigations because of their limited cellular complexity 
compared with human tumors and the ease with which they can be grown and 
manipulated under controlled conditions. However, as the in vitro microenvironment 
is substantially less complex than the environment in which cancer cells proliferate in 
vivo, the conclusions reached from cancer cell line investigations, although 
informative, may not be directly applicable to the natural setting in which human 
tumors arise, progress, and are treated. Given that the consequences of particular 
genetic alterations in cancer may be highly context dependent and governed by the 
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spatial and temporal involvement of multiple interacting components, identification of 
gene expression differences between in vitro proliferation and in vivo tumor growth 
potentially may uncover genes that play an important role in tumor formation. 
Global RNA expression profiling of xenograft tumors from human-derived cells grown 
in immune-compromised mice makes it possible to determine the extent to which 
cancer cells modify their expression profile in response to the local 
microenvironment. Gene expression profiling using oligonucleotide arrays represents 
an excellent means to study such tumor-host relationships in this setting because the 
potential background due to cross-species hybridization is minimal (bandapalli et al., 
2006). 
In this thesis, transcriptional changes in human LS174T colon adenocarcinoma cells 
grown orthotopically in the liver of nude mice were investigated to better mimic the 
environment of human liver metastasis. Potential host tissue response to the 
implantation of cancer cells were also examined using a mouse oligonucleotide array 
to measure the expression of mouse genes in liver tissue adjacent to tumor. To gain 
further insight into the contributions of various factors in the microenvironment of liver 
metastasis, transcriptional profiles of cells grown in vitro with profiles of orthotopically 
implanted tumors were compared. Furthermore the role of CXC chemokines and ß-
catenin genes was studied that were found to be up regulated in the invasion front. 
 
1.8 CXC chemokines    
The CXC chemokines are a unique family of cytokines for their ability to behave in a 
disparate manner in the regulation of angiogenesis. CXC chemokines have four 
highly conserved cysteine amino acid residues, with the first two cysteine amino acid 
residues separated by one nonconserved amino acid residue (i.e., CXC). A structural 
domain within CXC chemokine family dictates their functional activity. The NH2 
terminus of the majority of the CXC chemokines contains three amino acid residues 
(Glu-Leu-Arg: the ELR motif), which precedes the first cysteine amino acid residue of 
the primary structure of these cytokines (Strieter et al., 1995). Members that contain 
the ELR motif (ELR+) are potent promoters of angiogenesis (Luster et al., 2000& 
Belperio et al., 1998). In contrast, members that are inducible by interferons and lack 
the ELR motif (ELR-) are potent inhibitors of angiogenesis (Strieter et al., 2004).  The 
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angiogenic members of the CXC chemokine family include CXCL1, CXCL2, CXCL3, 
CXCL5 and CXCL8. The best described member is probably CXCL8 (IL-8). The 
ability of CXCL8 to promote endothelial cell survival and proliferation has been 
substantiated by a number of studies (Nor et al., 2001 & Li et al., 2003). Induction of 
the expression of CXCL8 in cancer cells by diverse signals and subsequent tumor-
associated angiogenesis has been shown (Strieter et al., 2004& Dong et al., 2001). 
The other pro-angiogenic members of the CXC chemokine family have been less 
extensively described (Strieter et al., 2004).  
The fact that all ELR+ CXC chemokines mediate angiogenesis highlights the 
importance of identifying a common receptor that mediates their biological function in 
promoting angiogenesis. The candidate CXC chemokine receptors are CXCR1 
and/or CXCR2. Only CXCL8 and CXCL6 specifically bind to CXCR1, whereas all 
ELR+ CXC chemokines bind to CXCR2 (Addison et al., 2002). The ability of all ELR+ 
CXC chemokine ligands to bind to CXCR2 supports the notion that this receptor 
mediates the angiogenic activity of ELR+ CXC chemokines.  While CXCR1 and 
CXCR2 are detected in endothelial cells (Addison et al., 2000, Murdoch et al., 1999 & 
Salcedo et al., 2000), the expression of CXCR2, but not CXCR1, has been found to 
be the primary functional chemokine receptor in mediating endothelial cell chemotaxis 
(Addison et al., 2000 & Murdoch et al., 1999et al.,) Another receptor which binds at 
least to CXCL1, CXCL5 and CXCL8 (Addison et al., 2004) and is expressed on 
endothelial cells is the Duffy antigen receptor for chemokines (DARC).  
The angiostatic members of the CXC chemokine family include CXCL4, 9, 10 and 11 
(Strieter et al., 2004). They are interferon-inducible. The putative receptor for 
angiostatic chemokines is CXCR3 (Strieter et al., 2004). Angiostatic effects of 
chemokines seem to be mainly attributable to immunologic effects involving T 
lymphocytes, and the paradigm of immunangiostasis has been postulated (Strieter et 
al., 2004). 
 
1.9 β-catenin 
β-catenin  is involved in cell-cell adhesion as well as in signal transduction and 
transcriptional activation of a huge number of target genes 
 (http://www.stanford.edu/~rnusse/pathways/targets.html).  
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For its action as transcriptional activator it has been shown to localize to the nucleus 
and associate to members of the TCF/LEF family of transcription factors (Brembeck 
et al., 2006 &  Huelsken et al., 2002). During cancer development this nuclear 
accumulation as well as overall increased protein levels seem to be caused by either 
stabilizing mutations of the gene itself or by mutations affecting components of the ß-
catenin degradation complex including the APC, AXIN1 or AXIN2 tumor suppressor 
genes (Brembeck et al., 2006 &  Huelsken et al., 2002).  In colorectal cancer, the 
second most common cancer in both sexes (Grem et al., 2001), nuclear localization 
has been mainly observed at the invasion front of primary tumors as well in liver 
metastases (Brabletz et al., 2001). One current concept interprets this finding as 
mechanism within the epithelial mesenchymal transition which takes place preferably 
at the invasive margin and leads to the acquisition of a less differentiated and more 
mesenchymal appearance (Brabletz et al., 2005). Posttranslational regulation is 
generally believed to be the main regulatory mechanism for β-catenin activity. 
However, increased mRNA levels have occasionally been reported in some types of 
cancers including colorectal (El-Bahrawy et al., 2001& Mann et al., 1999), gastric 
(Ebert et al., 2002), hepatocellular (Cui et al., 2001) and desmoid (Saito et al., 2002) 
cancer indicating at least some influence of transcriptional or posttranscriptional 
regulation. 
Aim of the thesis  
 17
1.10 Aim of the thesis 
Global RNA expression profiling of xenograft tumors from human-derived cells grown 
in immune-compromised mice makes it possible to determine the extent to which 
cancer cells modify their expression profile in response to the local 
microenvironment. Gene expression profiling using oligonucleotide arrays represent 
an excellent means to study such tumor-host relationships in this setting because the 
potential background due to cross-species hybridization is minimal.  
The thesis is majorly focused on two themes. Chapter 1 deals with the degree of 
interspecies overlap of genes between the syngenic model CT26 and human clinical 
specimen. 
Chapter 2, 3 deal with the analysis of global gene expression profiles and invasion 
front related genes in xenograft model.  
 
1. Interspecies comparison of gene and gene expression profiles in a 
mouse model of colorectal liver metastasis and in clinical specimens 
A. What is the degree of interspecies overlap on the single-gene level? 
B. How similar are gene expression patterns and single-gene expression in an 
interspecies comparison and can relations between these parameters in    
addition to histological assessment be used to explain interspecies overlap? 
C. Which gene expression patterns and selected marker genes can be 
considered typical for the different compartments? 
2. Global gene expression profiles of host tissue at the invasive front of 
colorectal liver metastases 
A To examine whether a xenograft nude mouse model of colorectal liver 
metastases would deliver reliable and valid data 
B     To provide comprehensive and unbiased study of the components of the  host 
reaction upon tumor invasion and  
C     To deliver potential target genes for the development of host cell directed 
therapeutics. 
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3. Gene expression profiles of tumor cells in vitro, in vivo and at the 
invasion front of colorectal liver metastases 
A     To explore the gene expression changes in tumor invasion front during 
confrontation with host tissue   
B     Gain insight in the activation of the β-catenin promoter in the invasion front of 
colorectal liver metastases.  
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2 Materials 
2.1 Instruments 
Autoclave Systec V-95 (Systec GmbH) 
Centrifuges MiniSpin & 5804R (Eppendorf) 
CO2-Incubator  Hera-Cell 150 (Heraeus)  
Laminar Air- flow HeraSafe (Hearaeus) 
Microscope  Axiovert 40 C (Carl Zeiss)  
MultiTM Image Light Cabinet Alpha Innotech 
PALM® MicroBeam-Laser-System 
 
P.A.L.M. Microlaser Technologies AG,  
Bernried, Germany 
PCR Machine Cyclone Gradient (PeQlab) 
pH Meter Meter SevenEasy (Mettler Toledo) 
Precisions Balance ABS 104-S (Mettler Toledo) 
Spectrophotometer Bio photometer (Biorad) 
UV Transilluminator Benda Laboratories 
Vacuum pump VaccuSafe (Integra Biosciences) 
Vortexer Reax Top (Heidolph) 
 
2.2 Chemicals and reagents 
1Kb Ladder Invitrogen 
dNTP Invitrogen 
ECL Amersham Pharmacia 
FCS Sigma Aldrich 
Lipofectamine 2000 Invitrogen 
Rainbow Protein Marker Amersham Pharmacia 
RNAsin Promega 
RPMI Invitrogen 
Skimmed Milk Powder Carl Roth 
 
2.3 Special Material 
Biomax Light Film Kodak 
Cell Culture Material Falcon, Greiner and Nunc Nalgene 
Membrane Slides for LCM Molecular Machines&Industries 
Microarray chips Affymetrix 
Nitrocellulose Membrane Hybond Amersham Pharmacia 
Whatmann Paper Whatmann 
2.4 Plasmids 
pSM2C Plasmid containing CXCL-1, IL-8 & non-silencing shRNAmir construct from 
Open Biosystems USA 
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pSEAPBhBCTNf1, pSEAPBhBCTNf2, pSEAPBhBCTNf3 containing fragment 1, 
2&3 of β-catenin promoter from BCCM/LMBP Plasmid&DNA Library collection, 
Belgium 
pBabe Puro containing puromycin resistance marker. 
 
Sh RNAmir Clone Sequences 
CXCL-1 (Accession No: NM_001511) 
Clone 1 (RHS1764-9681692)  
TGCTGTTGACAGTGAGCGCCCTGCACACTGTCCTATTATATAGTGAAGCCACAGA
TGTATATAATAGGACAGTGTGCAGGTTGCCTACTGCCTCGGA 
Clone 2 (RHS1764-9193979)  
TGCTGTTGACAGTGAGCGCCCTGCACACTGTCCTATTATATAGTGAAGCCACAGA
TGTATATAATAGGACAGTGTGCAGGTTGCCTACTGCCTCGGA 
 
CXCL-8 (Accession No: NM_000584) 
Clone 1 (RHS1764-9502516)  
TGCTGTTGACAGTGAGCGAGGGAGAATATACAAATAGCAATAGTGAAGCCACAGA
TGTATTGCTATTTGTATATTCTCCCGTGCCTACTGCCTCGGA 
Clone 2 (RHS1764-9210951)  
TGCTGTTGACAGTGAGCGCCGGAATAATGAGTTAGAACTATAGTGAAGCCACAGA
TGTATAGTTCTAACTCATTATTCCGTTGCCTACTGCCTCGGA  
 
2.5 Kits 
ECL Plus Western Blotting Detection Kit     Amersham Pharmacia  
Fast PlasmidTM Mini kit Eppendorf 
Light Cycler RNA Master SYBR Green I Roche  
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MegascriptTM High Yield Transcription Kit    Ambion 
Phospha-LightTM System Applied Biosystems 
Plasmid Maxi Kit Qiagen 
RiboAmpTM HS RNA Amplification Ki Arcturus 
RNA 6000 Pico LabChip Kit Agilent Technologies 
RNA Transcript Labelling Kit Affymetrix 
RNeasy® mini Kit Qiagen 
 
2.6 Cell Lines 
 LS174T Human colon adenocarcinoma cell line  
 CT26 Mouse colon carcinoma cells 
2.7 Reagents 
50x TAE-Buffer (1l)  
242g  Tris Base 
57.1ml  Glacial Acetic acid 
37.2g  Na2 EDTA, pH 8,0 
  
TE Buffer   
0.040M  Tris-acetate 
0.1%  Acetic acid 
0.002M  EDTA.2H2O pH 8.0 
  
Gel loading Buffer  
5% Glycerin 
166. 7 µM  EDTA 
0.0025% Bromophenol Blue 
  
PBS 10X, pH 7,4  
80g  NaCl   
2g  Kcl 
14.4g  Na2HPO4-7H2O   
2.4g  KH2PO4 
make upto 1l with H2O   
  
LB-Agar medium  
20 g/l  Peptone 
10 g/l  Yeast extract 
5 g/l  NaCl 
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15 g/l  Agar 
  
2x-LB broth (low-salt) Medium 
20 g/l  Peptone 
10 g/l  Yeast extract 
5 g/l  NaCl 
50µg/ml Chloramphenicol 
  
10X Laemmli running Buffer  
250mM  Tris base 
1.92M  Glycine    
1% SDS   
  
2X Laemmli sample buffer 
pH 6.8 0.12M  Tris-HCl 
20% V/V  Glycerine 
4% V/V SDS 
10%V/V  B-Mercaptoethanol 
  
Stacking Gel (5%)   
1.1ml H2O 
2.5ml 30% Acrylamide Mix 
1.3ml 1.0M Tris pH6.8 
0.05ml 10% SDS 
0.05ml 10% Ammonium Persulphate 
0.002ml TEMED 
  
Separating Gel (15%)  
0.68ml H2O 
0.17ml 30% Acrylamide Mix 
0.13ml 1.5M Tris pH6.8 
0.01ml 10% SDS 
0.01ml 10% Ammonium Persulphate 
0.001ml TEMED 
  
Transfer Buffer I  
36.33g  Tris Base in 600ml water (pH 10.4) 
200ml  Methanol 
Make upto 1l with water  
  
Transfer Buffer II  
3.03 g  Tris base in 600ml of water (pH 10.4) 
200ml  Methanol 
Make upto 1l with water  
  
Transfer Buffer III  
5.25g Norleucin 
3.03g  Tris Base in 600ml of water (pH 9.4) 
200ml  Methanol 
Make upto 1l with water  
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Z-Buffer+EDTA  
60mM  Na2HPO4 
40mM  NaH2PO4 
10mM  KCl 
1mM  MgSO4 
2.5mM  EDTA pH 8.3 
50mM  b-mercaptoethanol (3µl/ml) 
Make upto 1l with water  
  
Special Primers  
T7 Primer MBI Fermentas 
Oligo dT       Invitrogen 
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Human Specific Primers  
 
 
Gene                Primer sequence Ann.  
temp           
T(oC) 
Product      
size (bp) 
    
APAF1   60 124 
  For:   5’- AACCAGGATGGGTCACCATA -3’    
  Rev:  5’- ACTGAAACCCAATGCACTCC -3’    
APOF   62 110 
  For:   5’- TTCTGCACCCAAAGTCACTG -3’   
  Rev:  5’- ATCAGCCTGACAACCAGCTT -3’     
CDH1   65 110 
  For:  5’-AGGCCAAGCAGCAGTACATT-3’   
  Rev: 5’-ATTCACATCCAGCACATCCA-3’    
CXCL1  55 - 
 For:   5’-Qiagen Quantitech Primer-3’   
 Rev:  5’- Qiagen Quantitech Primer -3’   
CXCL2  55 - 
 For:   5’- Qiagen Quantitech Primer -3’   
 Rev:  5’- Qiagen Quantitech Primer -3’   
CXCL3  55 - 
 For:   5’- Qiagen Quantitech Primer -3’   
 Rev:  5’- Qiagen Quantitech Primer -3’   
CXCL5  55 - 
 For:   5’- Qiagen Quantitech Primer -3’   
 Rev:  5’- Qiagen Quantitech Primer -3’   
COL5A2   58 105 
  For:   5’- TGGAGAAGGTGGAAAACCAG -3’   
  Rev:  5’- TCTCCTCTTTCCCCAGGATT -3’   
CTNNB1  55 268 
 For:   5’- TTGGTAGGGTGGGAGTGGTTTA-
3’ 
  
 Rev:  5’- CAGGCCAATCACAATGCAAG-3’   
EpHB2   60 110 
  For:   5’- AGCATTACCCTGTCGTGGTC -3’   
  Rev:  5’- TTTATGGCTGTGGCGTTGTA -3’    
EREG   60 186  
  For:  5’- TTTGCTCTCAGCTGATGTGTCC -3’   
  Rev: 5’- TGGCCTTGGTTGAAGACCAT -3’  
 
  
IL-8 8CXCL8)  60 85 
 5'-CTC TTG GCA GCC TTC CTG ATT-3'   
 5'-TAT GCA CTG ACA TCT AAG TTC TTT 
AGCA-3' 
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Mouse specific primers 
 
 
 
 
 
 
 
 
MARCKS   58 189  
  For:   5’- CACCTTCTTCCTCTGCCTTG -3’   
  Rev:  5’- CCCATTGTGACCCCTATCAC -3’     
MARK3   58 120  
  For:  5’- TTCCGTTACCCTGAGAGTCG -3’   
  Rev: 5’- GCCAGTGTAGGGAGATGCTT -3’     
MPZL1   58 128  
  For:   5’- AAGGAAGCTGCTCACACTGA -3’   
  Rev:  5’- TCTGCAACCAGGAAAGGAGT -3’     
RHOB   60 106  
  For:   5’- ACAGCTTCAGCACAGCCTCT -3’   
  Rev:  5’- CGCTTATGGCAAAAACAACC -3’     
THBS2   58 124  
  For:   5’- TATTCCCGAGACCAACGAAG -3’   
  Rev:  5’- ACATCATCGTCACTCCCACA -3’    
18s RNA  60  
 For:  5’-AAACGGCTACCACATCCAAG -3’   
 Rev: 5’-CCTCCAATGGATCCTCGTTA -3’   
Gene Primer sequence  Ann temp 
 T ( oC) 
  Product 
   size (bp) 
 
      
Apof  62 124 
 For:  5’- ATACAGCCCAGCCGTCTAAA-3’   
 For:  5’- CCAGGGACAGAAAGGTTCAA-3’   
cRBP  58 229 
 For: 5´- GAGGCATGGTTCTGCACTGA -3`   
 Rev: 5´- CCGTGGCTTCTGATCCTTGT -3`   
Col5a2  58 210 
 For:  5’- ACACACGTGCCCAGTAATGA-3’   
 For:  5’- GGAAATCTATCCCAGCTTGC-3’   
cstb    58 151  
  For:   5’- TGAAGTCCCAGCTTGAATCG -3’   
  Rev:  5’- AGGGGTTGAAACACCCTCAA -3’    
ctsc    60 223  
  For:   5’- GGCAGTTGCCTTTGAAGTCC -3’   
  Rev:  5’- TCCTCTGCGGATACGGAAGT -3’    
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2.8 Antibodies  
Actin ICN Biomedicals 
α-Smooth Muscle Actin (Clone ASM-1) Cymbus Biotech 
ß-catenin BD Biosciences 
cRBP Santhacruz Biotechnology 
CXCL-1 R&D (Gift from Dr.Wente) 
Desmin (Clone D33)  Dako Cytomation 
Hep Par-1 (M7158)  Dako Cytomation 
Interleukin-8 Santacruz Biotechnology 
Transgelin (SM 22 α) Abcam 
ctss    60  178 
  For:   5’- ATTCAGCTCCCCTTTGGTGA -3’   
  Rev:  5’- TCCCATAGCCAACCACAAGA -3’    
Dfy   62  173 
  For:   5’- GCCTCATGGGATGGTTCTCA -3’   
  Rev:  5’- TGGTCTGATGGCAGAACAGG -3’   
Efnb2   59  176  
  For:  5’- TGTCATCGGTTGGCTACGTT -3’   
  Rev: 5’- CCAAAGCTGAACCAACTCCA -3’   
Eng   58 197  
  For:  5’- ATATGGCTGCCCGGGATTAC -3’   
  Rev: 5’- CCAACCGAAGTTGTGCCAGT -3’    
Flt1    60 176  
  For:   5’- CAGTGCAATCCCCACTGAGA -3’   
  Rev:  5’- ACACACTGCAGCCGACAAGA -3’    
GapDH  62 - 
 For:  5’-TGC ACC ACC AAC TGC TTA-3’   
 For:  5’-CCT GCT TCA CCA CCT TCT T-3’   
Gbp1    60 114  
  For:   5’- AGGGCAGCTGTCTTTGGGTA -3’   
  Rev:  5’- GCCAATCCCAGCTTAGAGCA -3’    
Gbp2    60 127  
  For:  5’- CGACTCCATTTTGGGGTCAC -3’   
  Rev: 5’- GCATGATGAAGGCCGAGAGT -3’   
Gbp3    60 171 
  For:   5’- CATAGCAGCTGAGCGGACAA -3’   
  Rev:  5’- TCCCTCAGCAGCATCTCCTT -3’   
α-SMA   58 280 
 For:  5’-CCTGACTGAGCGTGGCTATT-3’   
 Rev: 5’-CGCTGACTCCATCCCAATGA-3’   
Thbs2  58 108 
 For:  5’- GGGACCACACAAATTGATCC-3’   
 For:  5’- CCCAAACTCGTCGAAACCTA-3’   
Tie1   58  173  
  For:   5’- AGCCTCGAAACTGCGATGAC -3’   
  Rev:  5’- GATGCCCGCATAGGTGAAGT -3’    
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3 Methods 
3.1 Cell Culture and Animal Experiments 
Cell Culture 
LS174T human colon adenocarcinoma and CT 26 Mouse colon carcinoma cells were 
cultured in RPMI (PAA Laboratories GmbH) supplemented with 10% FCS (Sigma–
Aldrich GmbH), 2 mM glutamine, 100 IU/ml penicillin, and 50 mg/ml streptomycin 
(PAA Laboratories GmbH). Medium renewal was done two times per week.  
Cells were detached using Trypsin-EDTA (0.05% Trypsin/0.02% EDTA; PAA 
Laboratories GmbH) following standard protocols (Freshney et al., 1987). In order to 
freeze cells, cultures were detached and resuspended in 5 ml culture medium. Cells 
were pelleted by centrifugation at 1000 rpm for 10 min at 4°C. Pellets were 
resuspended in culture medium containing 10% DMSO (Sigma) to a concentration of 
1x106 cells/ml and stored at -800C 
For cell counting, cells were stained with one volume trypan blue (Sigma–Aldrich 
GmbH) to visualize apoptotic cells and counted using a haemocytometer (Neubauer 
chamber), according to standard protocols (Freshney et al., 1987).  
 
Animal Experiments 
For animal experiments we modified a previously described model in which tumor 
cells are injected into the spleen of nude mice, resulting in extensive liver metastasis 
(Dunnington et al., 1987). Six to eight week old female, athymic nude mice (NMRI-
nu/nu) (Möllegard and Bomholdgard Laboratories, Ry, Denmark) were anesthesized 
using Ethomidat (Radenarkon, Asta Medica Frankfurt, Germany) at a concentration 
of 40 µg/g bodyweight. They were subjected to a lateral abdominal incision extending 
just below the last left rib in a sickle shape of about 1 cm. The spleen was luxated 
and 50 µl of 5x106 LS174T-cells were injected into the tip of the spleen using a 30.5 
gauge needle. Alternatively, mice were subjected to a midline abdominal incision 
extending from the xiphoid process to just above the urinary bladder. The liver and its 
major blood vessels were exposed and 50 µl of 5x106 LS174T-cells were injected 
into the upper mesenteric vein using a 30.5 gauge needle. In a third model, 50 µl of 
5x106 LS174T-cells were injected along the margin of the large liver lobe. All three 
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models produce extensive liver colonization after a period of 2 to 4 weeks. At that 
time, animals were euthanized, livers were removed and 10 mm thick pieces 
containing tumor areas and liver were embedded in TissueTek OTC medium (Sakura, 
Tokyo, Japan), snap frozen in methyl butane, pre-cooled in liquid nitrogen, and stored 
at -80°C.  
3.2 Tissue preparation and laser microdissection (LMD) 
Frozen tissue blocks were cut into 8 µm sections using a cryostat (Leica, Wetzlar, 
Germany) and stained using Cresyl Violet. Briefly, the staining consisted of sequential 
incubations in 70% ethanol (1 min), Meyer’s hematoxylin (Sigma, Taufkirchen, 
Germany, 1 min), DEPC treated tap water (1 min), 2% eosin (10 s), 70% ethanol 
(30 s), 95% ethanol (2 x 30 s), and 100% ethanol (2 x 30 s). Thereafter, the sections 
were left to air-dry for 5-10 minutes. After microscopic control of staining quality and 
tissue preservation, the sections were used for microdissection using Leica AS LMD 
(Leica, Wetzlar, Germany), MMI (Molecular Machines & Industries, Eching, Germany) 
or PALM laser microdissection instrument (PALM Microlaser Technologies GmbH). 
Two distinct cell populations were separately microdissected for comparison between 
liver and invasion front liver: a) invasion front tissue extending 3 cell rows into the 
liver and 3 cell rows into the tumor, b) normal liver tissue at least 3 rows away from 
the invasion front. Microdissection was performed separately by three different 
scientists yielding material for three separate experiments (experiments 2-4, subject 
for RNA amplification). In addition, material for a fourth experiment was generated by 
the concerted action of all scientists (experiment 1, no RNA amplification). Four 
different distinct cell populations were microdissected for interspecies comparison 
and tumor versus tumor invasion comparison. a) Liver tissue atleast 3 cell rows away 
liver invasion front, b) liver invasion front 3 cell rows adjacent to the tumor invasion 
front, c) tumor invasion front 3 cell rows adjacent to the liver invasion front and d) 
tumor atleast 3 cell rows away from the tumor invasion front. After microdissection 
the slices were collected in tubes, added 50µl of Buffer RLT (Qiagen) and stored at -
80°C. 
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3.3 RNA extraction, quality control and quantification  
3.3.1 Extraction of total RNA from cell lines 
To extract RNA for microarray experiments, cells were quickly thawed at 37°C and 
pelleted at 1000 rpm for 10 min at 4°C prior addition of RLT Buffer (Qiagen). For 
quantitative RT-PCR experiments cells were detached by directly adding RLT Buffer 
(Qiagen) to the culture vessel. Total RNA was extracted according to the instructions 
given in the RNeasy mini kit manual. Briefly 1 volume of 70% ethanol (350µl) was 
added to the homogenized lysate and mixed well by pipetting slowly. 700 μl of the 
sample, including any precipitate that may have formed was transfer to an RNeasy 
spin column in a 2 ml collection tube and centrifuged for 15 seconds at10,000 rpm. 
Flow-through was discarded, 350 μl Buffer RW1 was added to the RNeasy spin 
column and centrifuged for 15 seconds at 10,000 rpm to wash the spin column 
membrane. 80ml of DNase was added to the centre of the column and incubated at 
RT for 15 min. 350µl o of RW1 was pipetted onto the spin column and centrifuged at 
10,000 rpm for 15 Sec. Flow-through was discarded and 500 μl Buffer RPE was 
added to the RNeasy spin column, centrifuged for 15 seconds at 10,000 rpm to wash 
the spin column membrane. 500 μl Buffer RPE was added to the RNeasy spin 
column, centrifuged for 2 min at 10,000 rpm. RNeasy spin column was placed in a 
new 2 ml collection tube and centrifuged at full speed for 1 min. RNA was eluted with 
30-50 μl RNase-free water by centrifuged for 1 min at 10,000 rpm to elute the RNA in 
a new 1.5 ml collection tube. 
3.3.2 Extraction of total RNA from snap-frozen and microdissected 
tissues 
H&E and Cresyl violet stained histological sections were prepared from each tissue 
prior to RNA extraction. Representative tissue areas, identified on the H&E stained 
histological sections, were microdissected as described in the Tissue preparation and 
laser microdissection section and used for RNA extraction. 350µl final volume of RLT 
Buffer (Qiagen) was added to 3-5 frozen tubes of each sample and total RNA was 
extracted as described above.  
(http://www1.qiagen.com/literature/handbooks/PDF/RNAStabilizationAndPurification/
FromAnimalAndPlantTissuesBacteriaYeastAndFungi/RNY_Mini/1035969_HB_Bench
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Protocol.pdf). To eliminate contaminating DNA, RNA was treated using the DNAse I 
system of Qiagen. 
3.3.3 Evaluation of RNA quantity and quality 
Total RNA concentrations were determined using a spectrophotometer. To assess the 
quality of total RNA from cells, 0.5–1 μg RNA was separated on conventional 0.8% 
agarose (Applichem GmbH) gels using 1 X TAE (prepared from 50 X TAE stock 
solution, see Appendix) as a running buffer (Ausubel et al.,1994.). Total RNA 
concentrations from microdissected samples were determined using RNA 6000 pico 
kit on an Agilent Bioanalyser instrument (Agilent technologies Deutschland GmbH) as 
described below  
 
Principle of Lab-on-a-Chip 
The electrophoretic assays are based on traditional gel electrophoresis principles 
that have been transferred to a chip format. The chip format dramatically reduces 
separation time and sample consumption. The system provides automated sizing and 
quantitation information in a digital format. On-chip gel electrophoresis is performed 
for the analysis of DNA, RNA and proteins.  
 
Figure 1: Lab-on-a-chip  (Source: Agilent Technologies) 
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The chip accommodates sample wells, gel wells and a well for an external standard 
(ladder). Micro-channels are fabricated in glass to create interconnected networks 
among these wells. During chip preparation, the micro-channels are filled with a 
sieving polymer and fluorescence dye. Once the wells and channels are filled, the 
chip becomes an integrated electrical circuit. The 16-pin electrodes of the cartridge 
are arranged so that they fit into the wells of the chip. Each electrode is connected to 
an independent power supply that provides maximum control and flexibility. Charged 
biomolecules like DNA or RNA are electrophoretically driven by a voltage gradient-
similar to slab gel electrophoresis. Because of a constant mass-to-charge ratio and 
the presence of a sieving polymer matrix, the molecules are separated by size. 
Smaller fragments are migrating faster than larger ones. Dye molecules intercalate 
into DNA or RNA strands or Protein-SDS micells. These complexes are detected by 
laser-induced fluorescence. Data is translated into gel-like images (bands) and 
electrophorograms (peaks). With the help of a ladder that contains fragments of 
known sizes and concentrations, a standard curve of migration time versus fragments 
size is plotted. From the migration times measured for each fragment in the sample, 
the size is calculated. Two marker fragments (for RNA only one marker fragment) are 
run with each of the samples bracketing the overall sizing range. The "lower" and 
"upper" markers are internal standards used to align the ladder data with data from 
the sample wells. This is necessary to compensate for drift effects that may occur 
during the course of a chip run.  
For RNA assays, quantitation is done with the help of the ladder area. The area 
under the ladder is compared with the sum of the sample peak areas. The area under 
the "lower" marker is not taken into consideration. For total RNA assays, the 
ribosomal ratio is determined, giving an indication on the integrity of the RNA sample. 
The 2100 expert software plots fluorescence intensity versus migration time and 
produces an electrophorogram for each sample.  
 
Protocol 
Briefly; RNA 6000 Pico dye concentrate was equilibrated to room temperature for 30 
min, vortexed for 10 seconds, spun down and added 1 μl of dye into a 65 μl aliquot of 
filtered gel. The solution was vortexed well and centrifuged at 14000 rpm for 10 min 
at room temperature. A new RNA 6000 Pico chip was placed on the Chip Priming 
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Station and 9.0 μl of gel-dye mix was pipetted in the well marked G. Chip Priming 
Station was closed and the plunger was pressed until it is held by the clip. Waited for 
exactly 30 seconds then released the clip. 9.0 μl of gel-dye mix was Pipetted in the 
wells marked G. 9.0 μl of the RNA 6000 Pico Conditioning Solution (yellow) was 
pipetted in the well marked CS. 5 μl of RNA 6000 Pico marker (green) was pipetted in 
all 11 sample wells and in the well marked Ladder. 1 μl of diluted ladder was loaded 
in well marked Ladder symbol and1 μl of sample in each of the 11 sample wells. Chip 
was placed in the adapter and vortexed for 1 min. at the set-point of the IKA vortexer 
(2400rpm). The chip was run in the Agilent 2100 bioanalyzer within 5 min. 
 
3.4 RNA Amplification (In Vitro transcription)  
3.4.1 Amplification of RNA for host-tumor interactions studies 
Microarray technology provides high-throughput analysis of gene expression profiles. 
However, using standard protocols, a substantial amount of RNA (50-100ug) is 
needed in order to apply this powerful technology. This molecular approach is thus 
rendered useless for many purposes if this limitation is not overcome.  
The increasing need to broaden the use of microarray technology has resulted in 
approaches to amplify the target RNA. Amplification of RNA has been developed and 
used in gene expression analysis before the microarray technique appeared. RNA 
amplification, unlike PCR amplification, is linear and not biased by the size of the 
template. In this method, mRNA is reverse transcribed with an oligo dT/T7 promoter 
primer. After synthesis of double stranded cDNA, antisense RNA is transcribed in 
vitro generally resulting in a 1000-fold amplification of the original amount. If 
necessary, a second round of amplification was performed simply by repeating the 
procedure. Amplified RNA was labelled with biotinylated NTPs and analyzed using 
microarrays.  
3.4.2 Reverse transcription (RT) of RNA and second strand synthesis  
RT was performed as previously described (Luo et al., 1999) with some 
modifications: 10 µl of the purified total RNA from RT was mixed with 2 µl dT24-T7-
Primer (20 µM (5’-GGC CAG TGA ATT GTA ATA CGA CTC ACT ATA GGG AGG 
CGG- (dT)243’, TibMolBiol, Berlin, Germany) to initiate first strand synthesis. Primer 
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and RNA were incubated for 5 min at 70 °C, followed by incubation for 2 min at 42 
°C. Next, 4 µl of 5x first-strand reaction buffer, 2 µl 0,1M DTT, 1 µl 10 mM dNTPs, 1 
µl 40 U/µl RNAsin (Promega, Mannheim, Germany) and 1 µl 200 U/µl Superscript II 
(Invitrogen, Karlsruhe, Germany) were added and incubated for 1 hour at 42 °C. 
Next, 91 µl RNase-free water, 30 µl 5x second-strand synthesis buffer, 3 µl 10mM 
dNTPs, 1 µl 10U/µl E. coli Ligase, 4 µl 10U/µl DNA-polymerase I und 1 µl 2U/µl E. 
coli RNase H were added and the mixture was incubated for 2 hours at 16° C, 
followed by a 5 min incubation step at 16°C after the addition of 2 µl 5U/µl T4-DNA-
polymerase. The reaction was stopped by the addition of 10 µl 0.5M EDTA at pH 8. 
cDNA was extracted with phenol-chloroform and NH4-acetate precipitation. The pellet 
was re-suspended 12 µl RNase-free water.  
3.4.3 T7-based RNA amplification  
First round T7-based RNA amplification was performed using the T7-Megascript-Kit 
(Ambion, Huntingdon, UK). 12 µl cDNA were mixed at room temperature with 2 µl T7-
buffer, 2 µl 40 mM NTPs and 2 µl enzyme-mix and incubated for 9 hours at 37°C. 
The aRNA was extracted with phenol-chloroform and NH4-acetate precipitation. The 
pellet was re-suspended in 10 µl RNase-free water.  
3.4.4 Subsequent rounds of aRNA amplification  
10 µl of aRNA from the first-round amplification were mixed together with 2 µl 50 
ng/µl random hexamers (Invitrogen, Karlsruhe, Germany), incubated for 10 min at 
70°C, and then chilled on ice and equilibrated at room temperature for 10 min. Then, 
4µl 5x first-strand buffer, 2 µl 0.1 M DTT, 1 µl 10 mM dNTPs, 1 µl 40 U/µl RNasin und 
1 µl 200 U/µl Superscript II were added and incubated for 1 hour at 37°C. 
Subsequently, 1 µl RNase H was added and incubated at 37° C for 20 min, after 
which the reaction mix was heated to 95° C for 2 min and chilled on ice. For the 
second-strand synthesis, 1 µl T7-(dT)24-primer was added and incubated at 70°C for 
5 min and at 42°C for 10 min. Next, 92 µl RNase-free water, 30 µl 5 x second-strand 
buffer, 3 µl 10 mM dNTPs, 4 µl DNA-Polymerase I and 1 µl RNase H were added and 
incubated at 16°C for 2 hours. 2 µl T4-DNA-polymerase were added and incubated at 
16°C for 10 min. The clean up of the double-stranded cDNA was performed as 
described for the first round of amplification. cDNA was then ready for second-round 
T7 in vitro transcription and RT which were performed as described for the first 
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round. Then, a third-round of aRNA amplification/labelling was performed as 
described in the Biotin labelled cRNA transcription section.  
3.4.5 Amplification of RNA for interspecies comparison studies 
RNA was amplified according to the instructions given in the RiboAmpTM HS RNA 
amplification kit manual (Arcturus GmbH;  
http://www.arctur.com/research_portal/images/pdf/riboamp_HS_userguide_verC.pdf 
and MessageAmpTM II-Biotin Enhanced Single Round aRNA Amplification Kit; 
Ambion (Europe) LtD. http://www.ambion.com/techlib/prot/fm_1791.pdf) 
 
3.5 Microarray hybridization and data analysis 
3.5.1 Generation of Oligonucleotide array probes 
Biotinylated cRNA target was generated15 from both, amplified and non-amplified 
cDNAs (2µg) using the Bioarray high yield transcription kit (ENZO, New York, NY) 
following the manufacturer’s protocol. After a 5-hour incubation period at 37°C, the 
final biotin-labelled cRNA product was purified using RNeasy spin columns (Qiagen, 
Hilden, Germany) and eluted in 30 µl of RNase-free water. The concentration of 
biotin-labelled cRNA was determined by UV absorbance. In all cases 20 µg of each 
biotinylated cRNA preparation were fragmented, assessed by gel electrophoresis and 
placed in a hybridization cocktail containing four biotinylated hybridization controls 
(BioB, BioC, BioD, and Cre) as recommended by the manufacturer.  
3.5.2 Hybridization 
Prior to hybridization to an Affymetrix microarray, a hybridization cocktail was 
prepared by using fragmented cRNA, probe array controls (hybridization control bio 
B, bio C, bio D, cre at a final concentration of 1.5, 5, 25 and 100 pMoles/l 
respectively; Control Oligonucleotide B2 50pmol/l), acetylated BSA 0.5mg/ml, 2X 
Hybridization Buffer (Final 1X concentration is 100 mM MES, 1M [Na+], 20 mM 
EDTA, 0.01% Tween-20) and Herring Sperm DNA 0.1mg/ml. The target was then 
hybridized to a Gene chip array as described in the affymetrix manual 
(http://www.affymetrix.com/support/downloads/manuals/expression_s2_manual.pdf). 
Labelled samples were hybridized for 16 hours with Gene Chip® Murine MGU74Av2 
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for liver and liver invasion front comparison; Gene Chip® Mouse Expression set 430 
and Gene Chip® Human Genome U133 set for interspecies comparison and Gene 
Chip® Human Genome U133 set (Affymetrix, Santa Clara, CA) for tumor and tumor 
invasion front comparison. A complete list of probe sets analysed in this arrays can 
be found at Affymetrix´s NetAffyxTM analysis center.  
(https://www.affymetrix.com/site/login/login.affx).  
The Affymetrix Gene chip technique makes use of a conjugate of Biotin-Streptavidin- 
Phycoerythrin (Biotin-SAPE) for labelling. The Biotin-SAPE conjugation is modified in 
the staining step after hybridisation. Hybridisation and staining is followed by 
scanning and storage of the image data. The information from a gene expression 
experiment (Affymetrix) is stored in several data files:  an  image  file (*.dat),  and  a   
*.cel  file  which  store  the  intensity  data calculated from the *.dat file.   The *cel file 
contains a single intensity value for each cell. The cell intensity data is then analysed 
and saved as a *.chp file, which contains qualitative and quantitative analysis for 
every probe set. In addition, an experiment information file and a report file are 
created. The report file summarises the data quality information from each single 
experiment from the *.dat file and contains a single intensity value for each probe cell 
delineated by the grid. The intensity data from the *.cel file is then analysed. 
Hybridisation controls (a mixture of fragmented cRNA from E.  coli and P1 
bacteriophage), that are spiked into the hybridisation cocktail, evaluate the sample 
hybridisation efficiency and can also be used to indirectly assess RNA sample quality 
among replicates. All hybridisation controls should be scored “present” in samples 
that show good hybridisation efficiency. Internal control probe sets are included in all 
arrays and are used to assess RNA sample and assay quality. House keeping genes 
like GAPDH and β-actin are commonly used. The ratio of the signal values between 
the 3´ probe set and the 5´ probe set (see above) should not exceed 3 for good 
quality assays. 
3.5.3 Percent Present 
The “Percent Present” (%P) is a measurement of the number of present probe sets in 
relation to the total number of probe sets on the array. The %P depends on a number 
of factors including cell origin, array type and RNA quality. Replicate samples should 
have similar %P values.  
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3.5.4 Scaling/normalisation 
There are many sources of systemic variation in a microarray experiment that affect 
the measured gene expression levels. The overall intensity between arrays should be 
similar and global scaling/normalisation is performed to minimise technical variation 
between arrays. Differences in overall intensity are most likely due to assay variables 
including pipetting error, hybridisation, washing and staining efficiencies, which are all 
independent of relative transcript concentration. For replicates and comparisons the 
scaling/normalisation factors should be comparable. Large discrepancies (e.g. three-
fold or greater) may indicate significant assay variability or sample degradation 
leading to noisier data. 
3.5.5 Data analysis 
In this study image analysis was performed with Affymetrix Gene Chip Operation 
Software version 4.0 (GCOS) to analyse the scanned images, convert intensities to a 
numerical format and obtain a detection call. This call indicates whether a transcript 
is reliably detected (Present) or not detected (Absent). The scanned images from the 
chips were processed using Affymetrix Microarray Suite 4.0, (Affymetrix Inc. Santa 
Clara, CA), NetAffyx, Microarray Database software, Excel (Microsoft, Seattle; USA) 
and GOSSIP (Microdiscovery, Berlin, Germany). 
3.5.6 Pair-wise comparison 
GCOS was used for pair-wise comparisons. During a comparison analysis, each 
probe set on the experiment array is compared to its counterpart on the baseline 
array (e.g.  Invasion tumor will be assigned as  “experiments” and tumor as 
“baseline”), and a change p-value is calculated indicating a Change call that is either: 
“Increase”, “Marginal Increase”, “Decrease”, “Marginal Decrease” or “No Change” in 
gene expression. First, comparisons yielding a “No Change” call were removed. 
Second, a Detection call, “Present” or “Absent” transcript, for each probe set was 
assigned. Then, probe signals that were “Absent” in both base line sample and 
experiment sample were excluded. The third metric was to sort on the relative 
change, fold change, in transcript abundance. GCOS uses a “Signal Log Ratio”. A 
fold change of 2 for increases or decreases corresponds to a Signal Log Ratio of 1 or 
-1 respectively. 
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3.6 RT-PCR and Gel Electrophoresis 
3.6.1 First-Strand cDNA Synthesis 
To 500 ng to 1µg of RNA in a 0.5-ml tube 1µl of 50 μM oligo (dT) 12-18, 1 μl of 10 
mM dNTP mix were added, total volume was made upto 10µl with sterile distilled 
water and incubated at 65°C for 5 min., quick chilled on ice and the contents of the 
tuber were collected to the bottom of the tube by brief centrifugation. 
4μl of 5X First Strand Buffer, 2 μl of 0.1M DTT and 1µl of RNaseOUT were added, 
the contents of the tube were mixed gently and incubated at 42°C for 2 min. 1µl of 
Superscript II was added to the tube, mixed by pipetting up and down and incubated 
for 50 min. at 42°C. The reaction was inactivated by heating the tube at 70°C for 15 
min. and cooled down to 4°C The cDNA was used as template for PCR reactions or 
stored at -20°C. 
3.6.2 Polymerase Chain Reaction (PCR) 
Polymerase chain reaction was performed to standardize protocols for qPCR and to 
check for specificity of the primers. A master mix was prepared containing all required 
reagents and aliquoted to PCR tubes according to the following protocol 
Master Mix: 
10X PCR Buffer 2.5µl 
10Mm dNTP mixture           0.5µl 
50mM MgCl2 0.75µl 
Primer Mix (10µM each) 1.25µl 
Template DNA (cDNA) 1.0µl 
Taq DNA polymerase 0.1µl 
 
Sterile DEPC treated water to a final volume of 25µl 
24μl master mix was aliquoted to each tube and 1μl of appropriate cDNA was added. 
Tubes were placed into PCR machine and required programme was chosen  
Initial Denaturation Step – 940C 3min 
Cycle Step 1 - Denaturation940 C 1min 
Cycle Step 2 – Annealing 55-600C 45 min (dependent upon primers used)  
Cycle Step 3 - Elongation 740C 1min  
Final Elongation Step - 740 C 3min 
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PCR products were either stored at 40 C or ran on a 1% agarose gel for analysis of 
the product. 
3.6.3 Gel Electrophoresis 
For the horizontal electrophoresis 0.6 to 3% agarose in 1X TAE with 0.2µg/ml EtBr 
was dissolved by heating. The probes were diluted with 1/5 volume of gel loading 
buffer and loaded into the wells along with ladder. The electrophoresis was run with a 
constant volume between 80-120v for 60-90 min. The bands were visualized under 
UV transilluminator and documented with Multi Image light cabinet. 
 
3.7 Quantification of mRNA expression levels using Light Cycler 
3.7.1 General principle of quantitative PCR  
PCR starts with a background phase followed by an exponential (or log) phase and 
ends in a plateau phase. Increase of PCR product during an amplification reaction 
can be detected by using the fluorochrome SYBR green, which binds to double 
stranded DNA, by the LightCycler system. 
 
During amplification, the number of PCR products present at a certain PCR cycle is 
described by the equation:  
N
n 
= N
0 
x E
n 
 
where N
n 
is number of products at PCR cycle n; N
0 
is initial number of product 
(template); E is amplification efficiency; n is number of PCR cycle  
Accurate DNA quantification is only possible in the log-phase of a PCR in which E is 
constant. In theory, the maximal amplification efficiency in log-phase is 2 so that 
every PCR product is replicated once per cycle. In practice amplification efficiencies 
in this phase are generally less than 2 due to many factors that could inhibit PCR 
reactions (suboptimal primers, PCR inhibitors in sample material etc.).  
To determine amplification efficiencies for individual PCRs, serial template dilutions 
have to be amplified on the LightCycler instrument. Standard curves and their slopes 
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are determined using the software provided by the LightCycler system. Amplification 
efficiencies are described by the equation:  
E = 10 
–1/-slope
 
where E is amplification efficiency; slope is slope of standard curve.  
The easiest way to determine absolute mRNA copy numbers of a gene of interest is 
to use an external standard, which is prepared from serial dilutions of RNA with 
known concentrations. Standard curves can be generated by amplification of the 
standard gene products on the LightCycler system (one-step RT-PCR). Based on 
these standard curves, concentrations of a target sample can be determined. 
However, quantification of mRNA copy numbers using this method do not necessarily 
reflect the actual and physiological expression level of a gene due to differences in 
isolation and storage of RNA. For these reasons, it makes sense to determine mRNA 
expression level of a gene of interest relative to a housekeeping/reference gene to 
adjust for alterations in mRNA copy numbers induced by experimental treatment. If 
this approach is used, separate standard curves have to be generated to determine 
the mRNA concentrations of the gene of interest and the reference gene in a given 
sample.  
Total RNA samples used in qRT-PCR were from the same preparations as described 
for the Affymetrix GeneChip experiments. However, to minimize any cross reaction 
artefacts, the liver part of the invasion front was microdissected separately from 
tumor; thereby defining new types of tissues (liver and liver invasion without tumor, 
Tumor Invasion without liver and Tumor). For each of the gene of interest identified 
from the GeneChip, primers were designed from the target sequences retrieved from 
the Affymetrix Probe Sequence Database using Primer3 software. Quantitative PCRs 
were carried out in duplicates using equal amounts of each RNA sample. Each 
reaction contained the fluorescent indicator SYBR Green I dye and 0.5µM of each 
respective forward and reverse primer in a total volume of 20 µL. Amplification PCR 
and monitoring of the fluorescent emission in real-time were done in Light Cycler as 
recommended by the manufacturer (Light Cycler RNA Master SYBR Green I 
protocol). The data collected from these quantitative PCRs defined as threshold cycle 
(Ct) of detection for the target or the housekeeping genes in each RNA sample. To 
convert the Ct value into a relative abundance of target and housekeeping gene per 
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sample, a standard curve was generated for the housekeeping gene using serial 
dilutions of RNA sample: an arbitrary value of template was first assigned to the 
highest standard and then corresponding values were assigned to the subsequent 
dilutions and these relative values were plotted against the Ct value determined for 
each dilution resulting in the generation of the standard curve. The relative amount of 
target and housekeeping genes in each sample was then determined using the 
comparative Ct method. The relative quantity of target, normalized to an endogenous 
reference (usually 18s RNA gene). 
3.8 Immunohistochemistry 
For immunohistochemistry, formalin fixed pieces of tumor bearing livers were paraffin 
embedded. 1.5 µm sections were deparaffinized with xylene and passaged through 
decreasing concentrations of ethanol. Subsequently antigen retrieval was performed 
by heating the slides in 10 mM citric acid in a microwave oven (two times 5 min, 560 
W) at pH 6.0. Sections were blocked against endogenous peroxidases using 3% 
H2O2 and were incubated with anti-ß-catenin, diluted 1:200 in PBS, at 4°C overnight. 
After washing and incubation with secondary antibody (anti-mouse/anti-rabbit; Vector, 
Burlingame, CA, USA) for 30 min. staining reaction was done using DakoCytomation 
AEC Chromogen (Dako GmbH, Hamburg, Germany) as substrate. For α-smooth 
muscle actin (α-SMA) staining, α-SMA detection was performed with a 1:100 diluted 
monoclonal mouse anti α-SMA antibody (clone asm-1, Cymbus Biotech, Chandlers 
Ford, UK), procollagen type I with a polyclonal antibody (Santa Cruz, sc-25974) at 
1:100 dilution, transgelin (SM22α) with a polyclonal antibody (ABCAM, ab 10135) at 
1:50 dilution and cellular retinol binding protein (cRBP-1) with a polyclonal antibody 
(Santa Cruz, sc-17145) at 1:100 dilution. As a secondary antibody, 1:300 diluted 
biotinylated anti-mouse IgG (Vector Laboratories, Buringame, CA) was used 
according to established protocols (Borkham-Kamphorst et al., 2004). The antibody 
reaction procedures were followed by treatment with an avidin-conjugated 
peroxidase (Vectastain ABC-Elite Kit, Vector Laboratories). Peroxidase activity was 
detected with diaminobenzidine (DAKO, Hamburg, Germany) and tissue sections 
were briefly counterstained with methyl green. For Hep-Par-1 and desmin staining, 
deparaffination and heat mediated antigen retrieval in 0.05 M citrate buffer of pH 6 of 
2 µm thin sections were followed by incubation with monoclonal antibodies. Hep-Par-
1 (DAKO, #M7158) is an antibody reacting specifically with hepatocytes in routinely 
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processed specimen (Wennerberg et al., 1993) and identifies an antigen unique to 
hepatocellular mitochondria (Lamps et al., 2003). Anti-desmin antibody (Clone D33; 
DAKO #M0760) was used to visualize HSC in quiescent as well as activated states 
(Geerts et al.; 2001) The primary antibodies were detected according to the alkaline 
phosphatase anti-alkaline phosphatase (APAAP) method using a rabbit-anti mouse 
secondary antibody (DAKO, #Z0259), a mouse monoclonal APAAP complex (DAKO, 
#D0651), and the Fast Red chromogenic substrate system (DAKO, #K0699). 
Haemalaun was used as a counterstain. 
3.9 shRNA 
A short sequence of RNA which makes a tight hairpin turn and can be used to silence 
gene expression. The use of specially designed vector constructs for inducing RNA 
interference has numerous advantages over oligonucleotide-based techniques. The 
most significant advantage is stability. Promoter regions in the vector ensure that 
shRNA transcripts are constantly expressed, maintaining cellular levels at all times. 
Thus, the duration of the effect is not as transient as with injected RNA, which usually 
lasts no longer than a few days. And by using expression constructs instead of oligo 
injection, it is possible to perform multi-generational studies of gene knockdown 
because the vector can become a permanent fixture in the cell line. 
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Figure 2: MicroRNA processing pathway utilized for shRNAmir (Source: Open 
Biosystems) 
  
3.10 shRNAmir design  
Expression Arrest shRNAmir triggers have been designed to mimic a natural 
microRNA primary transcript and each target sequence has been selected based on 
thermodynamic criteria for optimal small RNA performance (Silva et al., 2005) and 
cloned into pSM2 Vector. The clones were readily supplied in Bacterial stocks by 
Biocat GmbH for the gene of interest.  
Advantages of shRNAmir design 
Replaced mature microRNA sequence in mir-30 with gene specific duplexes  
Adding mir-30 loop and context sequences adds endogenous processing by Drosha 
which increases subsequent Dicer recognition and specificity 
Dicer processing promotes active loading into the RISC complex 
Rules based design include destabilizing the 5"end of the antisense strand for strand 
specific incorporation into RISC 
Increased Drosha/Dicer processing=More siRNA=Greater knockdown 
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Figure 3: Unique microRNA adapted design (Source: Open Biosystems) 
 
3.11 Extraction of Plasmid DNA  
3.11.1 Mini-Preparation 
Mini-preparation was usually performed to screen the recombinants following the 
isloation of plasmids from pSM2 vectors containing shRNA.  
The plasmid extraction was done according to manufacturer’s instructions. 
(Eppendorf Fast Plasmid Mini. Cat No 0032007.653). A single colony was grown 
overnight in 3 ml of 2X LB medium containing chloramphenicol to a final 
concentration of 50 µg/ml. The culture was incubated overnight at 37°C with vigorous 
shaking at approximately 250 rpm.  
An aliquot (1.5 ml) of the overnight culture was transferred to 2 ml culture tube, and 
centrifuged at max. speed for 1min. The pellet was resuspended in 400 μl of ice-cold 
complete lysis solution, mixed thoroughly by constant vortexing at the highest setting 
for a full 30 sec. and incubated at room temperature for 3 min.  The supernatant was 
transferred to a spin column assembly and centrifuged for 30–60 sec. at maximum 
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speed. 400 μl of diluted wash buffer was added to the spin column assembly and 
centrifuged for 30–60 sec. at max. speed. Filtrate was decanted from the spin column 
assembly waste tube and the spin column was placed back into the waste tube and 
centrifuged at max. speed for 1 min. to dry the spin column. Column was transferred 
into a collection tube and 50 μl of elution buffer was added directly to the centre of 
the spin column membrane and centrifuged at max. speed for 30–60 sec. The 
extracted plasmid DNA was further used to check for any uneventful recombinants in 
the clones. The remaining bacterial suspension was either stored as glycerol stock 
(15 %) or used for Maxi-prep.  
3.11.2 Maxi-Preparation 
Maxi-prep was typically done according to the protocol of the manufacturer. One 
hundred millilitres of 2x LB medium containing 50 µg/ml chloramphenicol was 
inoculated with either the bacterial glycerol stock or rest of the bacterial culture from 
the mini-prep. The culture was incubated over night at 37°C with vigorous shaking at 
approximately 250 rpm.The entire suspension was centrifuged at 12000rpm, 4°C for 
10 min in an Eppendorf B007 rotor. The pellet was resuspended in 10 ml of 
resuspension buffer containing 100 µg/ml of RNase A. Further a volume of 10 ml of 
lysis buffer was added. The sample was gently mixed and left for 5 min at RT to allow 
bacterial cell lysis. A volume of 10 ml of ice-cold neutralisation buffer was added and 
kept on ice for another 20 min. The suspension was centrifuged at 12000 rpm 4°C for 
1hr. The resultant supernatant was passed through a previously equilibrated Qiagen 
Tip 500 column. Once the solution was filtered, the column was washed twice with 30 
ml of wash buffer. Finally the DNA was eluted with 15 ml of elution buffer into a 
centrifuge tube. An additional 10.5 ml of isoproponal was added slowly to elute along 
the walls of the centrifuge tube. Immediately, the DNA precipitate could be visualised 
forming a white ring at the interface of the two solutions. The DNA was pelleted by 
ultra centrifugation for 1 hr at 12000rpm, and 4°C. The pellet was subsequently 
washed with 5 ml of 70 % ice-cold ethanol. Finally the pellet was air dried, and 
resuspended in appropriate amount of TE-buffer (pH 7.6). The purified DNA was 
stored at -20°C for further use.  
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3.12 Puromycin Dose-Response 
In order to generate stable cell lines expressing the shRNA of interest, it is important 
to determine the minimum amount of puromycin required to kill non-transfected cells. 
A simple procedure to quickly test this was used. Cells were plated at 25% 
confluence in 18 wells of a 24-well plate and grown overnight. The wells were 
labelled to reflect the concentration of antibiotic to be applied (in duplicate). Medium 
containing 0, 0.5, 1, 1.5, 2, 4, 6, 8, 10 μg/ml puromycin was prepared. Growth media 
was aspirated from the cells and medium containing appropriate dilutions of the 
antibiotic was applied to the wells. Plate was returned to the incubator. Every 3 days 
the old medium was aspirated and replaced with freshly prepared selective medium. 
The cells were monitored daily and the percentage of surviving cells was observed. 
Optimum effectiveness was reached in 5-7 days with puromycin. The minimum 
antibiotic concentration to use is the lowest concentration that kills 100% of the cells 
in 5–10 days from the start of antibiotic selection. 
3.13 Transfection 
3.13.1 Transfection of Cells with Plasmid DNA containing shRNA 
constructs 
The day before transfection, cells were plated in a 6 well plate so that they were 
approximately 2-3x106 confluent on the day of transfection. Arrest-In™ reagent was 
warmed to ambient temperature (approximately 10-15 minutes at room temperature) 
and mixed well by vortexing prior to use. For each well in transfection, plasmid DNA 
(4µg) and Arrest-In™ (10µg) were diluted in 50μl of serum-free medium each. Diluted 
DNA was added to the diluted Arrest-In™ reagent, mixed rapidly and incubated for 10 
minutes at room temperature. 100µl complex was added directly to cells in culture 
with existing growth medium and gently rocked back and forth. After 6 h incubation 
the transfection medium was aspirated and replaced with the standard culture 
medium. The cells were returned to the CO2 incubator at 370C. After 48 hrs of 
incubation, the cells were transferred to medium containing Puromycin (2µg/ml) for 
selection.  
3.13.2 Co-transfection of pSEAP plasmid with pBabe Puro 
LS174T were transfected with pSEAP plasmid DNA carrying different fragments of -
catenin promoter along with pBabe Puro plasmid harbouring puromycin selection 
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marker in 9:1 ratio. One day before transfection, 2-3 x 106 cells were plated in 2000 
μl of growth medium  so that cells were 90-95% confluent at the time of transfection. 
For each transfection 3.5µg of pSEAP and 0.5µg of pBabe puro Plasmid DNA was 
diluted in 50 μl of Opti-MEM® I Reduced Serum Medium and mixed gently. 10µl of 
Lipofectamine™ 2000 was diluted in 50 μl of Opti-MEM® I Medium, incubated for 5 
minutes at room temperature. The diluted DNA was combined with diluted 
Lipofectamine™ 2000 (total volume = 100 μl), mixed gently and incubated for 20 
minutes at room temperature. 100 μl of complexes were added to each well 
containing cells and medium. Mixed gently by rocking the plate back and forth and 
returned to 37°C in a CO2 incubator for 18-48 hours prior to testing for transgene 
expression. Medium was changed after 6 hours. For stable cell lines: cells were 
passaged at a 1:10 dilution into fresh growth medium 48 hours after transfection with 
2µg/ml puromycin.  
3.14 Protein preparation and quantification 
LS174T clones of CXCL1, IL-8, non-specific shRNA and mock-transfected LS174T 
cells were each plated in tissue culture flasks. After reaching confluency the cells 
were washed thrice with PBS and 200µl lysis buffer was added to the flasks and 
incubated for 10 min on ice with shaking and at -800C for 10 min. The lysate was 
transferred into eppendorf tubes, centrifuged for 5 min. at 40C and the supernatant 
was collected in new tubes. The protein content was measured by using Bio 
photometer and stored at -200C.  
3.15 Sodium dodecylsulphate polyacrylamide gel electrophoresis (SDS-
PAGE) and Western blotting (WB) 
 Appropriate volumes (10µg) of the samples were mixed with equal volumes of 2x 
Laemmli buffer containing SDS and mercaptoethanol, boiled for 10 min. at 1000C to 
denature the proteins and snap cooled on ice. Briefly centrifuged and Vertical mini 
gels was performed in a Biorad gel apparatus employing 5% stacking gel and 15% 
separating gel at 100 V (stacking gel) and 180 V (separation gel) in Laemmli 
discontinuous buffer. For WB performance, separated proteins were electro 
transferred onto nitrocellulose membrane (pore size 0.45 µm) for 60 minutes at 230 
mA by semi-dry transfer system (Scie-Plas, UK) using the buffer (Towbin et al.1979) 
After confirming the transfer of proteins by staining with 0.5% Ponceau solution, the 
membrane was destained with TBST. Unspecific binding sites were blocked with 
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TBST in 5%skimmed milk powder for 1h and the membranes were washed once with 
TBST. All steps of assay were performed by shaking at room temperature. After that, 
respective antibodies in TBST with 5%skimmed milk powder (CXCL-1 2µg/ml; IL-
80.2µg/ml R&D systems, Minneapolis, USA) were added to the membrane and 
incubated overnight at 40C. After washing four times for 15 min. each with TBST, the 
membranes were incubated for 60 minutes with Goat anti-mouse IgG-HRP; at 1:2000 
dilution (Santha Cruz Biotechnology, Santha Cruz, USA) or rabbit anti-goat IgG -HRP 
(Sigma, St. Louis, USA) at 1:4,000 dilution in TBST with 5% skimmed milk powder. 
Membranes were washed 6 times as before for 10 min. each. Excess buffer was 
drained off from the membrane and placed on a saran wrap facing the protein side up 
and ECL detection reagent was added on to the membrane and incubated for 5 min. 
Excess detection reagent was drained off from the membrane and placed on a new 
saran wrap and exposed to autoradiography film for suitable time in an x-ray 
cassette. 
3.16 Reporter gene activity (SEAP) measurement 
The Tropix® Phospha-Light™ system is a chemiluminescent reporter gene assay 
system designed for the rapid, sensitive, and non-isotopic detection of secreted 
human placental alkaline phosphatase in cell culture media. The Phospha-Light™ 
assay incorporates Tropix CSPD® chemiluminescent substrate and Emerald™ 
luminescence enhancer for high sensitivity and wide dynamic range. CSPD® 
substrate has been used for detection of secreted placental alkaline phosphatase in 
cell culture media (Cullen, B. et al.; 1992). The alkaline phosphatase assay is simple 
and rapid. Secreted placental alkaline phosphatase is measured from 48 to 72 hr 
after cell transfection. Cell culture medium or cell lysate is incubated with Reaction 
Buffer until maximum light emission is reached (approximately 20 min for culture 
media). Light output is then measured in a luminometer. Chemiluminescent assays 
for placental alkaline phosphatase may be conducted in cells that have endogenous 
alkaline phosphatase activity. Endogenous non-placental enzyme activity is 
significantly reduced by a combination of heat inactivation and differential inhibition 
that does not significantly inhibit the placental isozyme. It is important to determine 
the level of endogenous enzyme in media or extracts from non-transfected cells to 
establish assay background.  
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Protocol  
Sufficient CSPD® substrate was diluted to 1:20 with reaction buffer diluent to make 
reaction buffer (100µl/tube). Assay buffer and reaction buffer were equilibrated (100 
µl/sample) to room temperature. Sufficient 5X dilution buffer was diluted to 1X (300 
µL/sample) with H2O. Samples were prepared by diluting 100 µL of culture medium 
with 300 µL of 1X dilution buffer in a microfuge tube. Samples were heated at 65°C 
for 30 min. and then cooled on ice to room temperature.100 µL of sample and 100 µL 
of assay buffer were added to a luminometer tube and incubated for 5 min. To this 
100 µL of reaction buffer was added, incubated 20 min and measured in a 
luminometer for 1 sec/tube. All the assays were performed in triplicates.
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4 Results 
4.1 Interspecies comparison of gene and gene expression profiles in a 
mouse model of colorectal liver metastasis and in clinical specimens 
Invasion-related genes over-expressed by tumor cells as well as by reacting host 
cells represent promising drug targets for anti-cancer therapy. Such candidate genes 
need to be validated in appropriate animal models. This study examined the 
suitability of a murine model (CT26/ Balb/C) for the representation of clinical 
colorectal liver metastasis on a global gene expression scale. Interspecies similarity 
was examined through overlap of up-regulated genes, gene expression patterns 
(gene ontology-terms) and condensed pattern families between the respective 
compartments. In order to acquire cross-compartmental patterns and to generalize 
findings obtained in distinct animal models with respect to the clinical situation, global 
gene expression patterns were examined in a syngenic immunocompetent mouse 
model and in a set of five clinical samples of colorectal liver metastases. Histology 
and global gene expression data from four compartments namely liver, distant from 
the invasion front (L), liver adjacent to the invasion front (LI), tumor adjacent to the 
invasion front (TI) and tumor distant from the invasion front (T) were analyzed 
particularly concentrating on the following three questions: 
What is the degree of interspecies overlap on the single-gene level? 
How similar are gene expression patterns and single-gene expression in a 
interspecies comparison and can relations between these parameters in addition to 
histological assessment be used to explain interspecies overlap? 
Which gene expression patterns and selected marker genes can be considered 
typical for the different compartments? 
4.1.1 Intraspecies cross-compartmental correlation of histology and 
gene  expression 
To examine the degree of correlation of global gene expression changes to the 
histology within each species, the four compartments (liver, liver invasion, tumor 
invasion and tumor) were compared with each other on the gene expression scale 
separately for each species prior to interspecies comparisons. The number and 
percentage of differentially regulated genes (increase calls plus decrease calls) 
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between each of the four defined compartments was determined (Table 1). The 
comparison of tumor and tumor invasion compartments showed the lowest number of 
differentially regulated genes, followed by the comparison of pure liver and liver 
invasion compartments (Table 1, upper panel). Comparison of compartments of 
different histological origin displayed higher values (Table 1, lower panel) than 
compartments of identical histologic origin. These data indicate that the fact of 
different histological origin (e.g. tumor versus liver) is reflected on the level of global 
gene expression and is not clouded by background noise in this model. On the other 
hand, the observation that there are differentially regulated genes between L versus 
LI and T versus TI argues for a number of invasion specific processes in both species 
responsible for these differentially regulated genes.  
 
Table 1: Percentage of genes present (in at least one of two compartments) and 
total number of differentially regulated genes (increase plus decrease calls) 
 Human Murine 
Compartmental 
Comparisons 
% no % no 
 
T/TI 9.1±0.1 1519±9 22.5±0.9 3452±144 
L/LI 23.8±5.0 3785±797 25.6±3.5 3790±519 
TI/LI 28.8±4.4 5310±819 35.1±4.2 5683±675 
LI/T 34.4±4.8 5871±80 28.6±2.4 4327±363 
L/TI 37.8±0.1 6817±13 34.9±0.9 5458±138 
L/T 40.8±0.8 6555±127 35.0±0.9 5034±124 
 
L= liver, LI=liver invasion, TI=tumor invasion, T=tumor. 
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Figure 4: Histology of invasion fronts of liver metastases from the clinical 
specimen and from the murine model.  
HE staining of the invasion front of five clinical specimens (H1-H2) and murine tumors (M, 
CT26) growing in the livers of Balb/C mice. The human tumors were moderately to lowly 
differentiated adenocarcinomas with moderate stroma production and stroma reaction by a 
mild lymphocytic infiltrate. The tumor part of the invasion front did not differ strikingly from the 
inner parts. The liver displays an orderly structure with some fibrosis and a mild to moderate 
lymphocytic infiltrate in the portal tracts, no major pigments and mild to moderate fatty 
degeneration. The liver part of the invasion front contains mainly hepatocytes, but, in 
addition, an increased number of inflammatory and fibroblast like cells as well as sporadically 
ECM-like deposits. The murine tumor is a lowly differentiated to undifferentiated 
adenocarcinoma with little stroma production and little stromal reaction. As in the clinical 
samples the tumor does not significantly differ from the tumor part of the invasion front. The 
livers are of orderly structure with no apparent abnormalities. The liver part of the invasion 
front does not display gross differences to the liver except that the hepatocytes appear to be 
slightly flattened.  
Areas of microdissection are displayed exemplarily (H1). 
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4.1.2 Interspecies overlap of compartment-specific up-regulated 
genes, gene expression patterns and histological similarity 
The extent of interspecies overlaps of up-regulated genes were examined, which, in 
the invasion front, would represent potential target genes for tumor invasion. In 
addition, these findings were evaluated to see whether they would be paralleled by 
the histopathology and gene expression patterns. 
To determine the single-gene overlaps, files of IDs were created, which included all 
genes present in one particular compartment within one species that display an 
“increase call” (up-regulation) as compared to all other three compartments of the 
same species. 
Gene expression patterns were determined using the Gene Ontology tree with its 
branches “biological process”, molecular function” and “cellular component”. Thereby, 
those GO-terms which were “typical” for any of the 4 compartments were defined. To 
obtain these compartment specific GO-terms, the following algorithm was applied:  
Compartment specific up-regulated genes were selected as described above (test 
file). 
A reference file was created including all genes which are present in at least one of 
the four compartments.  
The distribution of the respective test files was compared to the distribution of the 
reference files in the GO-matrix (GOSSIP software).  
Interspecies syn-compartmental comparisons revealed that pure liver compartments 
showed the highest values among the species with a gene expression pattern 
overlap of 28% and a single-gene overlap of 16.4% (Table 2). Tumor invasion 
showed values of 10.9% (patterns) and 8.2% (single gene). Liver invasion 
compartments and tumor compartments displayed very low overlap-values (Table 2). 
These data indicate marked differences in the biological processes even in 
compartments of the same histologic origin. 
Although from different tissues of origin, cross-compartmental overlap was 
surprisingly high between human liver invasion and murine tumor invasion 
compartments (pattern: 16.5%, single-gene 6.3%). This result indicates that genes 
involved in invasion may overlap between the species independent from 
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histologically defined compartments. If up-regulated genes from both human invasion 
compartments were added and compared to both murine invasion compartments 
resulted in 9.0% overlapping genes as compared to only 4.6% of syn-compartmental 
comparisons (data not shown). Similarly, if up-regulated genes from both murine 
invasion compartments were added and compared to both human invasion 
compartments resulted in 5.6% overlapping genes as compared to only 2.9% of syn-
compartmental comparisons (data not shown).   
Relaxation of inclusion criteria dramatically increased overlapping genes in syn-
compartmental as well as cross-compartmental comparisons (Table 2, third panel). 
E.g., more than half of exclusively up-regulated genes in human liver (52.7%) were at 
least present (but not necessarily up-regulated) in the murine counterpart. However, 
syn-compartmental specificity was nearly lost (e.g. overlap of liver and tumor: 
43.8%). These data indicate that the number of overlapping genes can be increased 
by relaxing criteria but at the cost of compartmental specificity.  
 
Table 2: Interspecies gene expression pattern overlap  
 Single-gene overlap: up-regulated versus present 
 %     
(11754±347)  
%    
(13127±700) 
 %   
(13962±190) 
%    
(11562±131) 
L (999±156) 52.7(527±32.5) 51.7(517±45.3) 50.4(504±14.8) 43.8(438±41) 
LI (352±104) 41.2(45±52.3) 50.3 (177±68) 54.8(193±53) 48   (169±52) 
TI (170±84) 57.6(98±53.7) 60   (102±57.3) 71.8(122±67.2) 61.2(104±55.9)
T (320±81) 29.4(94±24) 35.6(114±29.7) 37.2(119±35.3) 30.6(98±38.1) 
 
             Murine  
Human 
L LI TI T 
 
Gene expression pattern overlap 
 %     (277±2)  %      (5±4)   %    (76±26)   %     (51±1.4) 
L (458±42 ) 28     (128±7.8) 0.28   (1±1.4)   2     (9±6.4)   1.7   (8±1.4) 
LI (133±11) 24.8  (33±0)       0        (0±0) 16.5  (22±1.4)   0.8   (1±0) 
TI (  46±31) 19.5  (9±3.5)    0        (0±0) 10.9  (5±7)  10.9   (5±1.4) 
T (  11±15) 27.2  (3±4)  0        (0±0) 45.5  (5±0)    0     (0±0) 
 
Single-gene overlap: up-regulated versus up-regulated 
  %    (635±5 )  %    (440±88)  %   (402±4)  %    (440±8.5) 
L (999±156) 16.4 (164±8.5) 3.0   (30±0.7)   1.0  (10±0)  1.1   (11±0.7)    
LI (352±104)   5.1 (18±3.5)     2.8   (10±6.4)     6.3  (22±9.2)     2.6   (9±2.8)   
TI (170±84)   1.8 (3±0.7)  0.6   (1±0) 8.2  (14±11.3)    5.3   (9±3.5)     
T (320±81)   0.9 (3±0) 1.3   (4±0.7)   4.7  (15±7.8)    1.6   (5±4.2)     
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First panel: percentage and total number (in brackets) of human GO-terms overlapping with 
murine) and single-gene overlap (lower two panels, percentage and total number (in 
brackets) of human genes overlapping with 1. up-regulated genes. Second panel or 2. genes 
present (third panel) in mouse). The total number of up-regulated genes or over-represented 
patterns for each compartment is indicated in the first column (human) and the first line 
(murine) of each panel.  
 
4.1.3 Gene expression patterns and pattern families 
Inorder to know the biological mechanisms responsible for the observed interspecies 
similarities and gene expression overlaps, GO-terms (biological processes, molecular 
functions and cellular compartments) fulfilling the following criteria were included into 
further analysis: 
Number of underlying genes per GO-term >9 
No terms of lower hierarchy clearly contributing to a significant higher node (e.g. 
exclusion of “collagen V” if “collagen” is significant) 
Only one out of two or more alternate and significant terms (either “steroid binding” or 
“steroid metabolism”)  
No very general GO-terms of highest hierarchical levels (e.g. “membrane”, 
“extracellular”). 
Application of these criteria resulted in 52 “core” GO-terms (Figure 2). For each GO-
term, a diagram was constructed based on the p-values for the four different 
compartments in both species (Figure 5). Such a diagram allows one to directly 
visualize in which compartment one particular GO-term is over-represented. 
Comparing the four bars to the left (human) with the ones to the right (murine) allows 
one to directly compare significant GO-terms between the two species. GO-term-
diagrams displaying the same compartmental distributions were grouped and the 
statistically significant compartments were indicated (Figure 5, framed). In principle, 
the 8 (2x4) examined compartments with significant p-values could be combined in 
256 possible ways (all possible combinations of 2-8 compartments=binomial 
coefficient n over k =n!/(k!(n-k)!)). However, only 10 combinations were actually 
found, indicating a non-random and probably biologically meaningful distribution of 
over-represented GO-terms among the different compartments. These 10 groups of 
GO-term diagrams with identical compartmental distribution were ordered into 
columns and were named according to the significant compartments (e.g. Lh or LIh 
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TIm, Figure 5, framed). Subsequently, GO-terms were grouped into pattern families 
by biological reasoning. 46 out of 52 GO-terms were assigned to 4 larger pattern 
families: Secondary metabolism, invasion, immune response and primary metabolism 
(Figure 5, different grey scales).  
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Figure 5: Compartmental distribution of compartment specifically over-represented 
GO-terms. 
GO-terms were selected as described in the text. GO-term-diagrams are ordered in columns 
according to their compartmental distribution. The respective significant compartments are 
indicated in bold. Each diagram consists of 4 human compartments (to the left) and 4 murine 
compartments (to the right).  
Abbreviations: Lh=human liver, LIh=human liver invasion, TIh=human tumor invasion, 
T=human tumor, suffix “m” indicates murine compartments respectively. 
Groups of GO terms with identical compartmental distribution are framed. Pattern families 
are indicated by different grey scales (see insert) 
 
A. Secondary metabolism 
The syn-compartmental interspecies evaluation revealed a huge number of GO-
terms belonging to secondary metabolism among the liver compartments in both 
species (Figure 5, column 1, dark grey). In contrast, none of the other three 
compartments showed over-representation of any secondary metabolism term 
indicating that this pattern family is liver specific. In addition, the human liver 
displayed some more metabolism terms that were not found to be statistically 
significant in the murine liver (Figure 5, column 2).  Some additional terms, not 
belonging to the secondary metabolism family were found to be over-represented in 
murine and human livers separately or in combination. 
 
B. Immune response 
GO-terms positioned either upstream or downstream of the marker term “Immune 
response” were distributed along the liver, liver invasion and tumor invasion 
compartments in both species (Figure 5, light grey). Only the tumor compartment did 
not show any significant “immune response” -related patterns. Different 
compartments seemed to be involved in innate and acquired immune response: The 
GO-terms “Innate immune response” (Figure 5) as well as “neutrophil activation” and 
“phagocytosis” (not shown) were over-represented in the liver compartments but not 
in any invasion front compartments. In contrast, the GO terms “antigen presentation” 
(Figure 5), and “antigen processing” (not shown) typical for the acquired immune 
response were over-represented in the invasion front compartments in both species, 
but not in the liver compartments.  
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C. Invasion 
GO-terms which have earlier been detected in a nude mouse model to be typical for 
invasion (Bandapalli et al 2006) were over-represented in both species in the 
invasion front compartments but not in any of the other compartments (Figure 5, 
darkest grey). Some terms such as “locomotion”/”cell motility” were over-represented 
in human liver invasion only, and others such as “signal transducer activity” were 
over-represented in murine tumor invasion only, while not reaching statistical 
significance in the other invasion compartments. Several GO-terms such as 
“extracellular matrix, “cell adhesion” and “differentiation”/”development” were over-
represented in the human liver invasion compartment and in the murine tumor 
invasion compartment. This finding indicates that the invasion compartments, in 
addition to immune response patterns (see above), display typical invasion-related 
patterns. Surprisingly only the murine tumor compartment and the human liver 
compartment displayed over-represented invasion terms. This phenomenon may 
indicate a high degree of similarity of human and murine tumor invasion on the 
pattern level, which, however, remains only true if the invasion front is examined as a 
whole. 
 
D. Primary metabolism 
In the murine but not in the human tumor compartment, a prominent “primary 
metabolism” cluster was found (Figure 5, lightest grey). This finding will be 
commented in the discussion section. 
In summary, these data indicate that GO-terms can be condensed by applying an 
inclusion algorithm and by simple biological reasoning to reveal four pattern families 
that include most GO-patterns and that seem to represent expected biological 
functions, at least in liver and invasion front compartments. 
 
4.1.4 Single-gene overlap within overlapping patterns 
Finally the data was examined to see, whether the observed low overlap on the 
single-gene level (Table 5, first panel) would still hold true if the constitutive genes of 
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actually overlapping GO-patterns were compared between the species. In addition, 
compartment-specific up-regulation of overlapping genes was confirmed on the 
mRNA level by qPCR.  
For the determination of single-gene overlaps within the “secondary metabolism” 
family two main metabolism sub-terms: “lipid metabolism” and “nitric compound 
metabolism” were chosen. As indicated in Table 3 (first panel), 16.1 % of human “lipid 
metabolism” genes and 17.8 % of human “nitrogen compound metabolism” genes 
were identical among the human and murine liver compartments. 
Table 3: Interspecies overlap of single genes underlying specific GO-terms  
 Human Murine Overlap 
 No. No. No. %  
Secondary metabolism 
Lipid metabolism 59   ±  5.7 63.5±2.1 9.5±2.1 16.1 
Nitrogen compound metabolism 53.5±10.6 24   ±1.4 9.5±2.1 
 
17.8 
Immune response 
Innate immune response 10.5±2.1 18±0 5±1.4 47.6 
Antigen presentation   6   ±0 12±2.8 2±0 
 
33.3 
Invasion 
Cell Adhesion 23±4.2 40.5±3.5 2±1.4   8.4 
Extracellular Matrix 20±4.2 21.5±2.1 3±1.4 15 
Upper three GO-terms from both liver compartments lower three GO-terms from human liver 
invasion and murine tumor invasion. Overlaps as total number and in percent of human 
genes. 
 
Compartment-specific up-regulation was verified on the arbitrarily selected 
apolipoprotein F gene from the “lipid metabolism” pattern. The gene showed the 
highest levels of mRNA in the liver compartment in both species (Table 4). Gene 
activity decreased with increasing distance from the liver compartment in both 
species. 
For the determination of single-gene overlaps within the “immune response” family 
two immune response terms: “innate immune response” and “acquired immune 
response” were chosen. As shown in Table 3 (second panel), 47.6 % of human 
“innate immune response” genes and 33.3 % of human “antigen presentation” genes 
were identical among the human and murine liver compartments. 
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For the determination of single-gene overlaps within the “invasion” family the terms: 
“cell adhesion” and “extracellular matrix” were chosen. As shown in Table 3 (third 
panel), 8.7 % of human “cell adhesion” genes and 15 % of human “extracellular 
matrix” genes were identical between the human liver invasion compartment and the 
murine tumor invasion compartments. 
Compartment-specific up-regulation was verified on arbitrarily selected genes from 
the “cell adhesion” and the “extracellular matrix” patterns. Both genes, 
thrombospondin-2 and procollagen V-alpha 2 showed the highest level of mRNA in 
the human liver invasion compartment and the murine tumor invasion compartment 
respectively (Table 4).  
 
Table 4:  Gene expression of selected genes typical for specific compartments 
 
Gene Name 
 
GO-term  L 
 
LI 
 
TI 
 
T 
 
Apolipoprotein F Lipid metabolism Human 100% 41.75% 17.4% 16.1%
  Murine 100% 26.5% 22% 7.9% 
       
Thrombospondin-2 Cell adhesion Human 21.6% 100% 22.7% 8.2% 
  Murine 4%     7.2% 100% 18.1%
       
Procollagen V-alpha 2 Extracellular matrix Human 12% 100% 73.5% 28.7%
  Murine     4%   20.6% 100% 14% 
 
RNA-levels in percent of gene expression of the compartment with highest RNA levels 
(=100%). 
 
Single-gene overlap of any “primary metabolism” patterns was not found because the 
GO-terms did not reach statistical significance in any of the other compartments.  
Altogether, these data indicate that single genes underlying overlapping GO-terms 
display interspecies identity to a varying degree.  In addition, up-regulation on 
microarrays was validated by independent qPCR on arbitrarily selected genes. 
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4.2 Global gene expression profiles of host tissue at the invasive front of 
colorectal liver metastases 
Invasion of tumor cells is dependent on a permissive host environment on the 
primary invasive site as well as on the site of metastasis.  
This study examined the potential change in gene expression profiles of the host 
invasive front in response to the invading tumor tissue in a xenograft mouse model 
(LS174T), where human colon adenocarcinoma cells growing in the livers of nude 
mice. Colorectal liver metastases are a particularly interesting target. From a 
therapeutic point of view this disease is of special interest because liver metastases 
often remain the only manifestation of the disease after removal of the primary tumor 
(Curley et al., 2004 and Grem et al., 1991) such that cure is possible if the 
metastases can be prevented or eradicated. Brand et al and Elezkurtaj et al have 
examined host cell targeting strategies for the treatment of colorectal liver 
metastases by liver cell directed over-expression of tissue inhibitor of 
metalloproteinases-1 and -2 (TIMP-1, TIMP-2) targeting the tumour host interaction 
(impregnation concept) (Brand et al., 2000 and Elezkurtaj et al., 2004). Although they 
observed dramatic reductions of metastatic tumor load, the precise nature of the anti-
metastatic mechanism remains to be based on circumstantial evidence. It is therefore 
the hope of this study that the examination of global gene expression patterns will 
shed some light onto the black box between hypothesis driven therapeutic 
experiments and the observed preclinical or clinical efficacy. 
This study has the following aims: 
1)  To examine whether a xenograft nude mouse model of colorectal liver 
metastases would deliver reliable and valid data,  
2)  To provide a comprehensive and unbiased study of the components of the 
host reaction upon tumor invasion and  
3)  To deliver potential target genes for the development of host cell directed 
therapeutics. 
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Figure 6: Areas subjected to microdissection 
Dotted line indicates demarcation for liver part of invasion front, which was used for qPCR.  
Bar=50 µm 
 
 
 
 
4.2.1 Gene expression profiles of host tissue in response to tumor 
invasion: Over-represented GO terms at the invasive front 
First goal for the global analysis of gene expression in the invasion front was to 
achieve patterns of gene expression which would either confirm known processes or 
provide additional insights into patterns of the biological processes in this region. 
To this extent minimal number of consistent gene expression patterns were defined 
by grouping all those genes, which are either up- or down-regulated in the host part 
of the invasion front. 
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The GO tree with its branches “biological process”, “cellular component” and 
“molecular function” served as the first matrix. The distribution of genes which were 
found to be at least 2 fold up-regulated in the liver part of the invasion front (test 
group) was compared to the distribution of a reference group which contained the 
whole group of all genes which were present in at least one of the tissues under 
examination (Change Call comparison, Table 5, columns to the left). Four different 
experiments resulting from four sets of separately microdissected material were 
analyzed separately. In addition, the distribution of genes which were present in the 
host part of the invasion front was compared to the distribution of genes which were 
either present in the host part of the invasion front or in the unaffected host tissue 
(Absolute Call comparison, Table 5 columns to the right). The Change Call 
comparison will reveal GO terms which are significantly over represented in the 
group of differentially up-regulated genes. The Absolute Call comparison will reveal 
GO terms which represent genes which are switched on in the invasion front while 
remaining inactive in the unaffected liver tissue. In all these analyses, cross reactive 
genes were eliminated as described in Bandapalli et al (Bandapalli et al., 2006). 
Statistical significance of differential representation of GO terms between test group 
and reference group was analysed by the GOSSIP software (Bluthgen et al., 2005) 
(http://gossip.gene-groups.net) which uses Fisher’s exact test corrected for multiple 
testing effects. Single-test p-values are included for completeness whenever the term 
was significant in at least one experiment after multiple testing corrections (FDR, 
false discovery rate).  
The above described analysis revealed lists of GO terms which were over 
represented in the respective test groups (Table 5). 
These GO terms were then manually clustered by first grouping together all terms 
within one track and then combining tracks from the three different main branches 
which belong together due to biological reasoning. 
By following these algorithms, 7 distinct groups of GO terms were defined which 
included 66 out of 68 significant GO terms resulting from the analyses (Table 5). 
The group of terms with the overall highest level of significance is best represented 
by the cellular component “extracellular matrix” and the related molecular function 
“extracellular matrix structural constituent” which displayed the highest level of 
Results  
 64
significance in all four Change Call experiments. These results indicate that there is 
an abundance of transcripts of extracellular matrix (ECM) components in the host 
part of the invasion front as compared to unaffected host tissue. In addition, ECM 
components are significantly over represented among those genes which are only 
present in the invasion front indicating that there is an activation of otherwise silent 
genes by the host upon tumor invasion. Among the genes, which are responsible for 
this finding, are collagens which seem also to be responsible for the 
overrepresentation of constituents of the basal membrane. 
The second group of GO terms which is consistently up-regulated in all 4 Change 
Call analyses is best represented by the biological process of “cell communication” 
which indicates increased interplay between the cells of the invasive front as 
compared to unaffected liver. Accordingly, “cell adhesion” / “cell adhesion molecule 
activity” are dramatically increased in the invasive front as well as “signal 
transduction”. 
 
Table 5: GO terms consistently up regulated in the liver part of the invasion 
front 
GO # GO Term  Change Call Absolute Call 
 Experiment 1 2 3 4 1 2 3 4 
5575 Cellular component (CC)  * *      
5576 Extracellular (CC) *** *** *** ** *  •  
5615 extracellular space (CC) *** *** ** • *  •  
5578 extracellular matrix (CC)  *** *** *** *** ° ° * ° 
5604 ..basement membrane (CC) ** *** *** *   °  
5605 ....basal lamina (CC) •  * •     
5581 ..collagen (CC) *** *** *** ***   •  
5201 extracellular matrix structural constituent (MF) *** *** *** *** * • •  
30020 ..extracellular matrix structural constituent conferring tensile strength activity *** *** *** ***     
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(MF) 
5539 glycosaminoglycan binding (MF) • * •      
          
9987 cellular process (BP) *** ** * ***     
7154 cell communication (BP) *** *** *** ***     
7155 ..cell adhesion (BP) *** *** *** ***     
7160 ....cell-matrix adhesion (BP)  *       
5194 cell adhesion molecule activity (MF) *** *** *** ***     
5886 ..plasma membrane (CC) • °  *     
          
7165 ..signal transduction (BP) ***   **     
1637 ….G-protein chemoattractant receptor activity (MF) *        
9605 response to external stimulus (BP) ***   * ** ° * * 
42330 ….taxis (BP) ** °       
6935 ……chemotaxis (BP) ** °       
42221 ……..response to chemical substance (BP) *        
9607 ..response to biotic stimulus (BP) ***   ** ** ° * * 
6952 ....defense response (BP) ***   ** ** • * * 
6955 ......immune response (BP) ***   ** * ° • • 
19884 ..........antigen presentation, exogenous antigen (BP) ** ** * •     
19886 ……..antigen processing, exogenous antigen via MHC class II (BP) *** ** * •     
45087 ……..innate immune response (BP) *  • •     
6954 ……inflammatory response (BP) **  • •     
19956 ….chemokine binding (MF) *        
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4950 ……chemokine receptor activity (MF) *        
45012 ……..MHC class II receptor activity (MF) ** ** * •     
9611 ..response to wounding (BP) *  • •     
     •     
5856 ….Cytoskeleton (CC) * ***  •     
15629 ……actin cytoskeleton (CC) * *       
15630 ……microtubule cytoskeleton (CC)  **       
5875 ……..microtubule associated complex (CC)  **       
5871 ……….kinesin complex (CC)  *       
5198 structural molecule activity (MF) ** *** ** °     
5200 structural constituent of cytoskeleton (MF)  ** *      
5488 binding (MF) ***  ° *     
5515 protein binding (MF) ***   *     
8092 ..cytoskeletal protein binding (MF) *** •  °     
3779 ..actin binding (MF) *** •  •  ° * * 
3782 ….F-actin capping activity (MF) * •       
7010 ……cytoskeleton organization and biogenesis (BP)  • °      
46872 metal ion binding (MF) *** •  *     
5509 ..calcium ion binding (MF) *** *** • ***     
6816 ..calcium ion transport (MF) *   °     
          
8283 ..cell proliferation (BP) °   *    * 
7049 ….cell cycle (BP) *   *     
910 ….cytokinesis (BP)    *     
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16049 ..cell growth (BP) *** *** • *     
1558 ….regulation of cell growth (BP) ** **  °     
19838 ..growth factor binding (MF) • **       
5520 ….insulin-like growth factor binding (BP) • **  °     
          
7275 development (BP)   * °     
30154 cell differentiation (BP)  • • °     
9653 morphogenesis (BP) °  • *     
9887 ..organogenesis (BP)   * •     
7517 ….muscle development (BP)  **       
45765 ……regulation of angiogenesis (BP) *  °      
          
30234 enzyme regulator activity (MF) °   • • ° * * 
4857 ..enzyme inhibitor activity (MF)     ** ° * • 
30414 ….protease inhibitor activity (MF)   °  **  * * 
4866 …...endopeptidase inhibitor activity (MF)   °  **  * * 
          
19835 ….cytolysis (BP) *  °      
5102 receptor binding (MF)  ° *      
 
GO distribution of genes up regulated in the liver part of the invasion front as compared to  
the control group (Change Call comparison, columns to the left). Distribution of genes solely 
present in the invasion front as compared to unaffected liver tissue (Absolute Call 
comparison, columns to the right). Number of asterisks indicates level of significance of GO 
term overrepresentation. Levels of significance (after multiple testing correction, FDR): 
***p<0.0005, **p<0.005, *p<0.05, 
Single-test p-values were included for completeness (•p< 0.02, ◦p<0.05), whenever the term 
was significant in at least one experiment after multiple testing corrections. Change Call and  
Absolute Call comparisons were examined independently.  
Different font (normal or italic) of GO numbers and term names indicate GO clusters obtained 
by biological reasoning.  
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Hierarchical levels are indicated by number of dots in front of GO terms.  
Abbreviations in brackets behind the GO terms indicated main GO branches; CC=cellular 
component, MF=molecular function, BP= biological process. 
 
The central term of the third GO cluster seems to be “response to biological stimulus” 
as the most significantly up-regulated node of the branch “response to external 
stimulus” which in addition is supported by “taxis” and “response to wounding”. 
Several immunological processes are up regulated in the invasive front. This GO 
group shows the highest overrepresentation among the Absolute Call comparisons of 
all 7 groups indicating that either cell populations which are not present in the 
unaffected tissue invade the invasion front or otherwise silent genes are expressed. 
A fairly large fourth group is formed by cytoskeletal molecules stemming from the 
microfilamental (actin) as well as the microtubular network. 
The fifth group consists of “cell proliferation” and “cell growth” including several sub 
nodes. 
The sixth group is headed by the main biological process “development” and consists 
of the sub node “cell differentiation” as well as “morphogenesis” with its related sub 
node “regulation of angiogenesis”. 
The seventh group consists of molecules with “enzyme regulator activity” including 
the molecular function “endopetidase inhibitor activity”. 
Only two terms, namely “cytolysis” and “receptor activity” could not clearly be 
assigned to one of the seven major groups by biological reasoning.  
To further rule out any major bias, which might have been introduced into the data set 
by excluding cross reactive genes from the analysis, Change Call comparisons were 
performed for experiment 1 with and without elimination of cross reactive genes. All 
GO terms, which had been significantly over represented in the invasion front in the 
cross reactive-negative data set, were confirmed in the cross positive-positive data 
set (data not shown). These results indicate that cross-reactive genes do not 
participate in differential gene regulation to an extent which would severely disturb 
the results of statistical analysis.   
Results  
 69
4.2.2 Gene expression  profiles of host tissue in response to  tumor 
invasion:  Under-represented GO terms at the  invasive front 
In a similar fashion as described above for up-regulated genes, Change call and 
Absolute call comparisons were performed for down-regulated genes. A huge number 
of GO terms were found by this type of analysis, namely 23 for “cellular component”, 
86 for “molecular function” and 85 for “biological process”. Among these terms the 
most reliably down-regulated terms were selected by including only those terms 
which are significantly down-regulated in at least three out of the eight analyses 
(Change call comparison and Absolute Call comparison) and which in addition 
display at least 5 asterisks in sum) as indicators of significance (Table 6). 
Among the significant GO terms as depicted in Table 6 , “mitochondrion” (cellular 
component, Table 6), “oxidoreductase activity” (molecular function, Table 6), and 
“electron transport” (biological process) are highly significantly down-regulated and in 
their combination clearly indicate a severely impaired respiratory chain in the cells of 
the invasion front. These terms are underscored by the significantly down-regulated 
terms “energy pathways” and “carrier activity” (Table 6, molecular function, Table 6, 
biological process).  
Nearly all areas of metabolism seem to be severely reduced in the invasion front like  
“lipid metabolism” (Table 6 c, biological process), “amino acid metabolism”, “aromatic 
compound metabolism”, “organic acid metabolism”, “amine metabolism”, “alcohol 
metabolism” and “monosaccharide metabolism” (Table 6c, biological process). 
Accordingly, several types of “catalytic activity” (Table 6b, molecular function) were 
significantly down regulated in several of the experiments although they did not reach 
the set threshold (except “lyase activity”). These data indicate that metabolic 
functions (“metabolism”, Table 6 b, molecular function) and “catalytic activity” (Table 6 
c, biological process) were very broadly down regulated in the invasion front. 
This pattern of GO terms suggests an impairment of hepatocellular functions and/or 
an under-representation of hepatocytes in the invasion front. Due to their physiologic 
function, hepatocytes are among the metabolically most active cells in the human 
body, and an impairment of hepatocellular functions or just a reduced number of 
hepatocytes may explain the very extensive overrepresentation of genes with 
catalytic activity and metabolism genes including those of mitochondrial metabolism 
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among the down-regulated genes in the invasion front. In addition, some typical 
hepatocellular functions were found to be down regulated although not always above 
the threshold for inclusion into Table 6. Examples are “blood coagulation”, (BP)/ 
“blood coagulation factor activity“(MF)/”complement activity” (MF), “alcohol 
metabolism” (BP, Table 6)/”alcohol dehydrogenase activity” (MF), “steroid 
metabolism” (BP, Table 6)/”steroid biosynthesis” (BP), “gluconeogenesis” (BP), “urea 
cycle” (BP) and “phenylalanine metabolism” (BP, Table 6)“/phenylalanine catabolism”. 
 
Table 6: GO terms consistently down regulated in the liver part of the invasion 
front 
GO # GO Term  Change Call Absolute Call 
 Experiment 1 2 3 4 1 2 3 4 
 CELLULAR COMPONENT         
5737 ...cytoplasm ***   *** *** * • *** 
5739 ....mitochondrion *** ** *** *** *** ** * *** 
42579 ….microbody *** *** *** * *   • 
5777 ……peroxisome *** *** *** * *   • 
5783 ….endoplasmic reticulum * * • ** * °  ** 
267 ..cell fraction ** *** *** * *  * ** 
5624 ..membrane fraction *** *** *** ** * ° ** ** 
42598 ….vesicular fraction *** *** *** *** ** * • *** 
5792 ......microsome *** *** *** *** ** * • *** 
 BIOLOGICAL PROCESS       •  
3824 .Catalytic Activity *** *** *** *** *** ** • ** 
16491 ..Oxidoreductase Activity *** *** *** *** ** ** • *** 
16705 …Oxidoreductase Activity acting on paired donors *** *** *** ** *   • 
6614 …oxidoreductase activity, acting on CH-OH group of donors * *** ** *     
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4497 …Mono Oxygenase activity *** *** *** *** * •  ** 
16712 
….oxidoreductase activity, acting on paired donors, with incorporation or 
reduction of molecular oxygen* 
** *** *** **     
16616 
….oxidoreductase activity, acting on the CH-OH group of donors, NAD or 
NADP as acceptor 
° *** ** *     
16829 ..Lyase Activity * *** ** ** *   * 
5386 ..Carrier Activity    ** ** *  * 
 MOLECULAR FUNCTION         
8152 .metabolism ** *** *** ** *** • ° * 
6118 ..electron transport *** *** *** *** * * • *** 
6082 ..organic acid metabolism *** *** *** *** * ° • * 
19752 ….carboxylic acid metabolism *** *** *** *** * ° • * 
6629 ..lipid metabolism *** *** *** * ** °  * 
6631 ….fatty acid metabolism * *** ** • *    
8202 ….steroid metabolism  ** **  •   ** 
6725 ..aromatic compound metabolism ** *** ** ** * *  * 
6519 ..amino acid and derivative metabolism *** *** *** ***    * 
6520 ….amino acid metabolism *** *** *** ***     
9063 ……amino acid catabolism *** *** ** ***     
9072 ……aromatic amino acid family metabolism ** *** ** ***     
6558 …...L-phenylalanine metabolism * ** * *     
6570 ……tyrosine metabolism ** ** * **     
9308 ..amine metabolism *** *** *** ***     
9310 ….amine catabolism *** *** ** ***     
Results  
 72
5996 ….monosaccharide metabolism  ** ** *     
19318 …...hexose metabolism  ** ** *     
9058 ..biosynthesis * • ** ** *** °  *** 
8610 ...lipid biosynthesis * ** ** ° •   * 
6066 ..alcohol metabolism * *** *** * ° •  * 
6091 ..energy pathways  * * **    * 
 
GO distribution of genes down regulated in the liver part of the invasion front as compared to 
control group (Change Call comparison, columns to the right). Distribution of genes solely 
present in the unaffected liver tissue as compared to the invasion front (Absolute Call 
comparison, columns to the right). Number of asterisks indicates level of significance of GO 
term overrepresentation. Levels of significance (after multiple testing correction, FDR): 
***p<0.0005, **p<0.005, *p<0.05,  
Single-test p-values were included for completeness (•p< 0.02, ◦p<0.05), whenever the term 
was significant in at least one experiment after multiple testing correction. Change Call and 
Absolute Call comparisons were examined independently. 
Different font (normal or italic) of GO numbers and term names indicate GO clusters obtained 
by biological reasoning. 
Hierarchical levels are indicated by number of dots in front of GO terms. 
 
 
4.2.3 Confirmation of stellate cell activation at the invasive front 
In order to confirm the suspected activation and myoblastic transdifferentiation status 
of HSC in the invasion front, qPCR and immunohistochemistry was performed with 
several genes which have been described to participate in these processes. The 
commonly HSC activation marker α-SMA showed in real time PCR a 2.9 fold 
difference in crossing points between liver and liver part of the invasion front which 
corresponds to a 7.9 fold higher gene expression in the invasion front as compared to 
unaffected liver (Table 7). In addition, histological sections were stained against α-
SMA. As shown (Figure 7a), α-SMA activity seems to originate mainly from cells with 
elongated nuclei which are directly lining the central part of the invasion front i.e. the 
border between tumor and liver tissue. A similar immunohistochemical pattern (Figure 
7b) was found for the cytoskeletal protein transgelin which was up regulated 6.5 fold 
in the qPCR (Table 7A). Procollagen type I was up regulated 4.5 fold in the qPCR 
(Table 7A). The protein seems to be predominantly localized to cells with small nuclei 
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(Figure 7c), which probably correspond to HSC. Staining seems however to extend a 
little further into the liver tissue. This tendency is even stronger with cRBP-1 which is 
clearly not only expressed in the invasion front but also in unaffected liver (Figure 
7d). In addition, besides HSC, hepatocytes seem to express cRBP-1 as well, which 
has been described before (Schmitt-Graff et al., 2003). According to the qPCR, 
cRBP-1 is up regulated 4.9 fold.  
Altogether, these data confirm the up-regulation of several HSC genes in the invasion 
front by two independent methods.  In addition to the several other genes which are 
up regulated at the invasion front of liver compared to the liver were confirmed qPCR 
(Table 7B) 
 
 
Table 7: Determination of differentially regulated gene levels in liver and liver 
part of the invasion front 
 
A 
Gene Liver Liver invasion
front 
ΔCrossing 
points 
Fold 
change 
(EΔcp) 
Smooth muscle α-actin 
Exp. 1 32.2 28   
Exp. 2 32.2 28   
Raw value (mean) 32.2 28 4.3  
Normalized on GapDH 
and efficiency corrected 
31.5 28.7 2.9 7.5 
Transgelin (SM 22 α 
Exp. 1 26.5 23.9   
Exp. 2 25.1 23.5   
Raw value (mean) 25.8 23.7 2.1  
Normalized on GapDH 
and efficiency corrected 
 23.1 3.3 8.6 
Cellular retinol binding protein (cRBP-1) 
Exp. 1 28 26.1   
Exp. 2 24.8 24.2   
Raw value (mean) 26.4 25.1 1.3  
Normalized on GapDH 
and efficiency corrected 
27 14.5 2.5 5.7 
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B 
Gene Name  Gene 
Symbol 
Upregulation 
(Fold Change) 
Cathepsin C Ctsc 5.3 
Cathepsin S Ctss 5.8 
Cystatin B Cstb 8.5 
Endoglin Eng 1.6 
Tyrosine kinase receptor 1 Tie1 2.9 
FMS-like tyrosine kinase 1 Flt1 3 
Guanylate nucleotide binding protein 1 Gbp1 22.3 
Guanylate nucleotide binding protein 2 Gbp2 6.4 
Guanylate nucleotide binding protein 3 Gbp3 2.5 
Endothelial-specific receptor tyrosine kinase Tek 3 
Eph receptor B4 Ephb4 1.95 
Ephrin B2 Efnb2 2.9 
Chemokine (C-X-C motif) receptor 2 CXCR2 1.4 
 
Total RNA of microdissected liver and liver part of the invasion front were isolated as 
described for hybridization experiments. 1.5 ng of total RNA were used for quantification. 
Obtained raw values of crossing points were normalized by GapDH values to correct for RNA 
quality. In addition, differences in PCR amplification efficiencies of GapDH and candidate 
genes were accounted for by calculation of the respective efficiencies in serial two-fold 
dilutions of non-microdissected tissue-RNA and normalization to the obtained ratio. The 
observed differences in crossing points were transcribed into fold changes according to 
efficiency values. 
 
In order to examine whether activation of HSC is accompanied by increased relative 
number of HSC in particular in relation to hepatocytes, HSC were stained against 
desmin, which has been reported to stain quiescent as well as activated HSC. 
Hepatocytes were stained with the antibody Hep-Par-1. Immunostaining revealed 
gradual differences in cellular distribution in the invasion front, the two extremes of 
which are displayed in the two upper panels of Figure 8. Staining against hepatocytes 
reveals areas of direct contact between hepatocytes and tumor cells as well as 
regions where these two groups of cells seem to be separated by a narrow and cell 
poor strip containing cells of different morphology (Figure 8, B, E). These patterns 
were hardly distinguishable by ordinary HE staining (Figure 8, A, D). 
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Figure 7: Immunohistochemistry for detection of activated HSC 
 
Slides were stained against α-SMA (A), transgelin (B), procollagen type I (C) and cRBP-1 (D) 
and counterstained with methyl green. 
T= tumor, L=liver, I= invasion front, V=blood vessel. Bar=50 µm 
 
Staining against desmin shows that the areas of close contact of hepatocytes and 
tumor cells do not show any net increase of HSC in the invasion front as compared to 
unaffected liver. Here, HSC seem to cover a significant but minor portion in the 
invasion front and liver and even seem to populate the tumor. In contrast, HSC seem 
to be the main population in the area where tumor cells and hepatocytes are 
separated by a cell poor strip. These results underscore the crucial role of HSC for 
the deposition of ECM as indicated by our gene expression analysis. 
In addition, the lower panel of figure 8 shows that HSC apparently take part in 
structuring the tumor tissue as they are lining intratumoral septi. 
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Figure 8: Immunohistochemistry for detection of hepatocytes and HSC 
 
Representative sections were stained with HE routine stain or alternatively immunostained 
against a mitochondrial hepatocyte marker or against the HSC marker desmin and 
counterstained with hemalaun. 
Upper panel (A-C): area of close contact of hepatocytes and tumor cells 
Middle panel (D-F): area of separation of hepatocytes and tumor cells by a cell poor strip 
Lower panel (G-I): area which includes an intratumoral fibrous septum 
T= tumor, L=liver, I= invasion front. Bar=50 µm 
 
4.3 Gene expression profiles of tumor cells in vitro, in vivo and at the 
invasion front of colorectal liver metastasis 
Metastatic tumor epithelia encounter specific host reactions during metastatic 
invasion into host tissue. This study was focused to examine how gene expression 
changes if cells from cell culture are grown in vivo in the inner parts of a tumor and in 
the invasive margin 
The transcriptional changes in human LS174T colon adenocarcinoma cells grown 
orthotopically in the livers of nude mice were investigated to better mimic the 
environment of human liver metastasis. To gain further insight into the contributions 
of various factors in the microenvironment of liver metastasis, gene expression 
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profiles of cells grown in vitro were compared with profiles of orthotopically implanted 
tumors and with profiles at the invasion front of tumor.  Use of xenograft mouse 
model helped to distinguish between host and tumor part of the invasion front by 
deleting cross reactive genes.   
 
Figure 9: Areas subjected to microdissection 
Dotted line indicates demarcation for tumor part of invasion front which was used for qPCR.   
Bar=50 µm 
 
4.3.1 Elimination of cross reacting genes leads to a tolerable loss of 
genes 
By applying a human tumor cell line growing in murine liver, species differences of 
gene sequence for discrimination of differential gene expression of host (murine) and 
tumor (human) genes was used. A critical determinant for the usefulness of the 
xenograft model was the level of cross reactivity of the murine tissue on the human 
chips which should be as low as possible. Invasion liver tissue was not used for 
determination of cross reactivity of murine samples on human chips because the 
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invasion liver tissue although predominantly consisting of liver cells consists in part of 
tumor epithelia of human origin which would obscure real cross reactivity if hybridized 
on human chips. Therefore RNA from liver cells was used as the representative 
samples for examination of cross hybridization of mouse liver tissue on human chips. 
The percentage of cross-reactive Affymetrix-IDs was 7% (Table 8).  
Table 8: Murine tissue (Liver) cross reacting with human chips 
Call Present Marginal Present + 
Marginal 
Absent Total 
Number of IDs 2679 498 3177 41643 44820 
Percentage (of total IDs on chip) 6% 1% 7% 93% 100% 
 
Number and percentage of present calls resulting from hybridisation of RNA from nude 
mouse liver tissue on U 133A and B human genome chips. Quality of cross reacting sample 
was examined on test chips. 
Because of this level of cross hybridization, we next evaluated to which extent the 
elimination of cross reactive genes would reduce the gene pool still available for 
further analysis of differential gene expression. Before deletion of cross reactive IDs, 
the first criteria that IDs have to be present at least in in vitro,Tumor or invasion front 
was applied (Table 9, upper and upper line). Then, cross reactive genes (transcripts 
from liver cells hybridising on human chips) were subtracted from the resulting pool of 
IDs (Table 9, upper and middle line). As expected from the small fraction of cross 
reactive genes, only 14.6% (on average) of murine genes hybridizing on human chips 
had to be deleted due to cross hybridization of their human counterparts (Table 9, 
lower line). This analysis indicates that deletion of cross hybridizing genes leads to a 
tolerable loss of IDs for further analysis. 
 
Table 9: Elimination of cross reactive gene (presernt or marginal in liver) 
Criteria                          Compartment Invasion front Tumor In vitro 
Cross reactive genes included 12991 15607 12361 
Cross reactive genes excluded 10858 13461 10066 
Percent reduction 16% 14% 14% 
 
Elimination of cross reactive genes leads to an only moderate reduction of the gene pool for  
further analysis 
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4.3.2 Degree of tumor cell Specialization increases with increased 
contact to host cells 
First goal for the global analysis of gene expression was to examine gene expression 
changes when cells from cell culture are grown in vivo and in the invasive margin. 
To this extent, minimal number of consistent gene expression patterns were defined 
by grouping all those genes that are up- or down-regulated between the 
compartments (in vitro to in vivo to invasion front and vice versa). 
The distribution of genes which were found to be at least 2 fold up-regulated in the 
specific compartment (test group) was compared to the distribution of a reference 
group which contained the whole group of all genes which were present in at least 
one of the tissues under examination (Bandapalli et al., 2006).  
Comparison of global gene expression profiles using gene ontology terms and 
GOSSIP software revealed an overall increase of cellular specialization from the in 
vitro to the in vivo situation and a further increase of specialization from tumor to 
invasion front. The analysis resulted in overrepresentation of 28 GO terms in in vivo 
and 41 in the Invasion front compared to in vitro The number of GO terms 
overrepresented between in vivo to the invasion front were 18. There was no under 
representation of GO terms from the invasion front to the tumor where as 4 GO terms 
were found to be under represented from invasion front and tumor respectively to in 
vivo (Figure 10).  
IF 18
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Figure 10: Number of GO-terms over represented in pair wise comparisons 
 
Genes which were at least two fold up-regulated between the respective pair wise 
compartmental comparisons were subjected to pattern analysis with Gossip software 
(Microdiscovery GmbH, Berlin). The direction of the arrow indicates the compartment with the 
up-regulated genes. 
IF= invasion front, T=tumor, IVT= cells in vitro 
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These GO terms were then manually clustered by biological reasoning. Among the 
patterns specific for the in vivo situation are “cell adhesion” and “actin cytoskeleton 
organisation (Figure 11A). An invasion specific and in vivo specific pattern is “signal 
tranducer activity” (Figure 11C).  
Further examination of the GO terms revealed in vitro specificity of “ribosome” and 
“protein biosynthesis” (Figure 11B) patterns. Invasion specificity of “signal transducer 
activity” is due to G-Protein coupled receptors (GPCR) but not tyrosine kinase 
receptors as they are in vivo specific (Figure 11C lower panel). A purely invasion 
specific pattern is “cell communication” (Figure 11D). The group of terms with the 
overall highest level of significance is best represented in in vivo pattern (cell 
adhesion) followed by in vivo and invasion pattern (cell communication). 
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Figure 11: Levels of significance (p-values) of GO-terms over represented in pair 
wise comparisons.  
 
A: in vivo pattern, B: In vitro pattern, C: in vivo and invasion pattern and D: Invasion patterns 
Genes which were at least two fold up-regulated between the respective pair wise 
compartmental comparisons were subjected to pattern analysis with Gossip software 
(Microdiscovery GmbH, Berlin). 
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4.3.3 Regulation of Pro-angiogeneic CXC chemokines 
A particularly important question from a basic scientific and particularly from a (gene) 
therapeutic point of view is the cellular origin of differentially expressed genes. Using 
GO-based GOSSIP software all secreted genes were determined in the epithelium of 
the tumor part of the invasion front and the epithelium of the inner parts of the tumor 
which have been reported to be associated with vasculature development. All growth 
factor-like genes were examined for differential gene expression. Most of the well 
known classical pro-angiogenic molecules were present in invasion front and tumor 
core but were not differentially regulated (Table 10).  
 
Table 10: Presence of angiogenic growth factors in tumor cells and their 
respective receptors in host cells 
Angiogeneic 
growth factor 
(tumor cells) 
Change call Receptor 
(host) 
Change call 
VEGF NC FLT1,KDR NC/NC 
P(L)GF NC FLT1,KDR NC/NC 
Angiopoietin-1 NC TIE-2 NC 
PD-ECGF-1 NC   
Angiogenin NC   
 
Examination of gene expression between tumor cells of the invasion front and those 
from the inner parts of the tumor or between host cells of the invasion front and those 
of the liver further away from the invasion front reveals the lack of differential gene 
expression (no change, NC). The lack of differential gene expression of VEGF has 
been confirmed by qPCR (not shown).  
In contrast, one class of pro-angiogenic molecules, the ELR+CXC chemokines was 
differentially regulated. All pro-angiogenic members of that family including potent 
pro-angiogenic CXCL8 (IL-8) were up regulated in the tumor cells of the invasion 
front as compared to the tumor core (Table 11). Moreover, angiostatic CXC 
chemokines like CXCL9, 10, 11 do not seem to be expressed by the tumor cells or at 
least not at a higher level in the invasion front (data not shown).  
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Table 11: Pro-angiogenic CXC chemokines in tumor cells 
 
         
  
 
All five chemokines have been found to be up-regulated in the tumor cells of the 
invasion front as compared to the tumor cells of the inner part of the tumor.  
These results may indicate that, ELR+CXC chemokines as compared to other pro-
angiogenic molecules may have a more specific role during the early steps of 
angiogenesis e.g. for the recruitment of endothelial cells into the tumor stroma.  
 
4.3.4 Targeted down-regulation of CXCL1 and CXCL8 expression 
using shRNA 
As ELR+CXC chemokine expression was elevated at the invasion front as compared 
to the inner parts of the tumor in the xenograft model, a shRNA–based approach to 
down-regulate CXC Chemokine expression in LS174 cells was used to determine if 
this played a contributory role in determining their invasive phenotype and 
angiogenesis. Appropriate shRNA and nontargeting control plasmids were 
constructed and transfected into LS174T cells, and puromycin-resistant colonies 
were expanded and tested for CXC chemokine expression. shRNA transfected 
clones (shCXCL1&ShCXCL8) showed inhibition of CXCL1 & CXCL8 expression as 
judged by quantitative real-time PCR using gene specific primers, whereas clones 
transfected with a non-targeting control vector (NTC) showed similar levels of CXCL1 
and CXCL8 expression as the parental LS174T cells. These data were further 
confirmed by Western blotting (Figure 12). Thus, stable targeted down regulation of 
CXC chemokine 
(tumor cells) 
Change call Fold 
change  
CXCL1 Increase 19.6 
CXCL2 Increase 2.8 
CXCL3 Increase 1.7 
CXCL5 Increase 6.8 
CXCL8 Increase 2.7  
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CXCL1 and CXCL8 expression using shRNA plasmids can be achieved with a high 
degree of inhibition. 
 
 
 
Figure 12: Inhibition of CXCL1 and CXL8 expression in LS174T cells.  
 
Upper Panel: 
A. CXCL1: 1) shNTC; 2) shCXCL1#1; 3) LS174T cells; 4) shCXCL1#2 B.  
CXCL8 (IL-8): 1) shCXCL8#1, 2) shNTC; 3) Ls174 T cells; 4) shCXCL8#2  
Lower panel:  
ß- actin of the respective samples 
 
Confirmation of up regulated genes in the invasion front of tumor compared to the 
inner parts of tumor by qPCR 
Table 12: Conformation of differentially regulated gene levels in tumor and 
tumor part of the invasion front 
Gene Name  Gene 
Symbol 
Upregulation 
(Fold Change) 
Apoptosis Protease activating Factor APAF 2.7 
E-Cadherin CHD1 4 
Myristoylated Alanine-Rich protein Kinase C 
Substrate 
MARCKS 15.9 
MAP/microtubule affinity-regulating kinase 3 MARCK3 6.9 
Myelin protein zero-like 1 MPZL1 2.8 
Ephrin receptor 2 EpBH2 7.5 
Epiregulin EREG 2.5 
Beta Catenin CTNNB1 3.4 
Lectin, Galactoside-binding, Soluble, 1  LGALS 2.9 
Ras Homolog gene family, member B RHOB 4.3 
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Total RNA of microdissected liver and liver part of the invasion front were isolated as 
described for hybridization experiments. 1.5 ng of total RNA were used for quantification. 
Obtained raw values of crossing points were normalized by GapDH values to correct for RNA 
quality. In addition, differences in PCR amplification efficiencies of 18sRNA and candidate 
genes were accounted for by calculation of the respective efficiencies in serial two-fold 
dilutions of non-microdissected tissue-RNA and normalization to the obtained ratio. The 
observed differences in crossing points were transcribed into fold changes according to 
efficiency values. 
 
Normalization of qPCR  
To normalize qPCRs, standard curves for -catenin (Gene of interest) and 18s RNA 
(reference) were established. For this purpose, serial dilutions of mRNA were 
prepared. Serial dilutions of gene of interest and reference gene were amplified on 
the LightCycler (Figure 13). Standard curve slopes were –3.980 for 18s RNA and  
–3.535 for ß-catenin resulting in PCR efficiencies (E) of 1.78 and 1.92, respectively 
(Figure 13A).  
Melting curve analysis confirmed specificity of PCR reactions. Melting of 18sRNA and 
ß -catenin PCR products resulted in single melting-peaks for 18sRNA and ß -Catenin 
(Figure 13B).   
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Figure 13: Calibration of quantitative RT-PCR.  
 
Standard curves for 18sRNA and β -catenin; (B) Melting curve analysis of 18sRNA and ß -
catenin indicating the specificity of both PCR reactions. Unspecific primer-dimers occurred in 
no template control of 18sRNA. 
 
4.3.5 Activation of the β-catenin promoter in the invasion front of 
colorectal liver metastases 
All adhesion related genes were examined for differential gene expression. Well 
known classical pro-oncogenic molecule -catenin was found to be up regulated in 
the invasion front compared to the inner parts of the tumor. To address transcriptional 
regulation of β-catenin the established in vivo model of colorectal liver metastases 
from human LS174T colon carcinoma cells growing in the nude mouse was used 
which allowed to evaluate micro environmental influences on tumor development 
(Bandapalli et al., 2006). Influence of a complex environment on β-catenin 
expression was studied by comparison of β-catenin expression in tumor cells in vitro, 
in the interior of the tumor and at the invasion front.  The dual species nature of the 
model allowed to monitor gene expression in tumor cells irrespective of 
contaminating stromal cells (Bandapalli et al., 2006). The LS174T colorectal 
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carcinoma cell line that was used in this animal model harbours a stabilizing β-
catenin mutation at codon 45 (Rowan et al., 2000). Accordingly, β-catenin protein was 
readily detected by Western blotting in LS174T cell lysates (Figure 14a, left band) 
and by immunohistochemistry in vitro (Figure 14b). A marked increase of the β-
catenin level was detected once the tumor cells grew in vivo (Figure 14a, right band). 
A further increase was seen in tumor cells growing at the invasion front (Figure 14 c, 
d). This is the first report of increased β-catenin levels in vivo in comparison to cell 
culture. According to yet unpublished data (manuscript in preparation) on global gene 
expression of tumor cells in the animal model, a distinct in vivo pattern of genes, to 
which β-catenin apparently belongs to, exists at the tumor invasion front. In addition 
to the increased -catenin mRNA level redistribution of β-catenin to the nucleus at 
the invasion front was observed however, not at a comparable degree as described 
before (Brabletz et al., 2001).  
 
 
Figure 14: Elevated levels of β-catenin in vivo.  
 
A. Elevated levels of β-catenin in vivo  
A. Western blotting: Increased levels of β-catenin in the interior of the tumor in vivo (right 
band) compared to cells grown in cell culture (left band).  
B, C, D. Immunohistochemistry: LS174 cells cultured in vitro (B) and in vivo (C,D). Increased 
ß -catenin staining occurs at the invasion front of the tumor (IT). 
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To examine whether mRNA levels paralleled protein, qPCR was performed from 
microdissected samples. As shown in Figure 15 a, β-catenin mRNA was elevated 
2.7-fold in tumor cells grown in vivo versus cells grown in vitro and another 3.4-fold at 
the invasion front compared to the interior of the tumor. In total, ß-catenin mRNA 
levels were increased 9.6 fold at the invasion front versus those in vitro. Our data 
indicate that ß-catenin is up regulated on the transcriptional level in response to 
changes in the tumor microenvironment. Increased mRNA levels of β-catenin have 
been reported to occur in a number of human cancers as compared to the respective 
normal tissue of origin (El-Bahrawy et al., 2001& Mann et al., 1999, Ebert et al., 
2002, Cui et al., 2001 & Saito et al., 2002) However, this is the first report 
demonstrating a response of cancer cells to the in vivo situation or the situation of 
being confronted with host tissue of the invasion front.  
To examine whether increased mRNA levels were indeed due to transcriptional up-
regulation, LS174 T cells were stably transfected with the human alkaline 
phosphatase reporter gene under the control of two different β-catenin promoter 
fragments which have been described before (Nollet et al., 1996). Activity of the two 
promoter fragments was evaluated by determination of both, reporter protein by 
luminescent activity and reporter gene mRNA levels by qPCR. As assessed by 
SEAP-mediated luminescence, the two fragments displayed a β-catenin promoter 
activity of 147 fold (fragment 1, position -298 to +139) and 190 fold (fragment 2, 
position -4700 to +1300) above background in LS174T cells in vitro (Figure 15 b). 
Because SEAP protein activity cannot be measured in microdissected samples from 
in vivo experiments, the suitability of qPCR for assessment of promoter activity was 
examined. As shown in Figure 15 c, SEAP mRNA levels were 831 fold (fragment 1) 
and 1448 fold (fragment 2), respectively above background. These data indicate that 
levels of reporter protein (Figure 15 b) were paralleled by levels of mRNA as 
assessed by qPCR specific for SEAP mRNA (Figure 15 c).  Using either method, 
fragment 2 was shown to be more active than fragment 1 and the ratio of fragment 2 
to fragment 1 regarding the fold changes above background is 1.3 for protein and 1.7 
for mRNA respectively indicating comparability of the methods. Our data are in good 
agreement with the initial report by Nollet et al. (Nollet et al., 1996) who had used a 
murine epithelial cell line (NMe), although in LS174T cells the difference on the 
protein level was not as prominent which may be ascribed to species differences. In 
addition, according to our results, promoter activity is apparently better reflected on 
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the mRNA level (higher values) than on the protein level, which might reflect 
posttranslational modifications of the protein. 
 
Figure 15: β-catenin promoter activity in vitro and in vivo. 
A: Levels of β-catenin mRNA in LS 174 T tumor cells in vitro, in the interior of the tumor and  
in the invasion front.  
B, C: β-catenin promoter activity in vitro  
D: Activity of the β-catenin promoter in LS 174 T tumor cells in vitro, in the interior of the 
tumor and in the invasion front.  
 
To examine promoter activity in vivo, liver metastases were induced with genetically 
modified cells (one cell clone harbouring fragment 2) and control cells as described 
above. To determine promoter activity, tumor invasion front and tumor compartments 
were microdissected as described above. Quantification of promoter activity was 
performed with qPCR specific for human alkaline phosphatase mRNA.  As shown in 
Figure 15 d, SEAP reporter gene mRNA was elevated 3.5-fold in cells grown in the 
tumor versus in vitro growth and another 18.4 -fold in cells grown at the invasion front 
compared to cells in the interior of the tumor. In total, this reflects a 64 -fold activation 
of the -catenin promoter in cells grown at the invasion front versus those in vitro. In 
principle, reporter gene mRNA levels (Figure 15 d) parallel β-catenin mRNA levels 
(Figure 15a) and protein levels (Figure 14), indicating that activation of the β-catenin 
promoter is responsible for increased mRNA and protein levels, at least in part. 
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However, the dramatic promoter activation at the invasion front does not seem to be 
entirely reflected by β-catenin RNA and protein levels indicating some 
posttranscriptional and/or posttranslational modifications.  
 
Discussion  
 91
5 Discussion 
5.1 Interspecies comparison of gene and gene expression profiles in a 
mouse model of colorectal liver metastasis and in clinical specimens 
Murine models represent a necessary tool in cancer research. However, there is 
always an uncertainty about the extent to which findings in the animal can be related 
to the human situation. In this study global, gene expression profiling in addition to 
standard histopathologic examination was used in judging the suitability of a murine 
model of colorectal liver metastases for the detection of invasion front target genes. 
The central observation was a decrease in overlap from the level of pattern families 
through single gene ontology patterns to the single gene level.  Although the central 
processes are fairly similar between the species, the percentage of overlapping 
potential target genes in interspecies syn-compartmental comparisons was at 
maximum 8.2% of the up-regulated genes among respective invasion front 
compartments in our system.  In other words, there is only a limited chance that 
invasion relevant genes that are detected in clinical samples will display a similar 
regulation in exactly the same compartment in a standard animal model of tumor cell 
injection. If, conversely, a target gene validation project starts with the animal model, 
one cannot necessarily expect that target genes arising from the murine invasion 
front are really relevant for exactly the same clinical situation. The number of 
overlapping genes can be significantly increased if those invasion relevant genes are 
included which show cross-compartmental overlap or are even up-regulated in liver 
compartments. In addition, relaxation of inclusion criteria leads to an increase of 
potential target genes. However, both modifications of the initial targeting strategy 
decrease specificity of the approach. 
Histopathology, pattern analysis and single-gene analysis in our system turned out to 
be complementary methods to achieve some understanding of differences and 
similarities between the clinical and the animal model situation.  
5.1.1 Inherent species differences  
Differences of liver tissue compartments far from the invasion front may represent the 
degree of dissimilarity between the species of only marginally affected organs. Data 
indicate that the biology of human livers as compared to the livers of Balb/C mice is 
not exactly the same as only 16.7% up-regulated genes were found to be 
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overlapping. It is likely that these inherent dissimilarities of the host tissue will have a 
severe impact on the mechanisms in the invasion front.  
Although this present approach is to our knowledge the first whole genome 
interspecies approach for invasion, several other interspecies comparisons on a 
more or less genome- wide scale have been performed. It is however difficult to 
compare data due to differences in methods and models. Sometimes, an 
encouraging similarity between the species is reported such as in a microarray meta-
analysis of the complex biological phenotype of aging. Here, the authors identified an 
expression signature common to the aging transcriptomes of mouse, man and rat at 
least within some organs (Wennmalm et al., 2005). A nice correlation of gene 
expression data from a rat liver cancer model with clinical cytogenetic abberration 
profiles resulted in the identification of several pathways involved in human liver 
cancer (Fang et al., 2005)  In contrast, even on the level of one single-cell type in 
vitro, marked interspecies differences have been observed in a massive parallel 
signature-sequencing approach, which identified only a small (core) set of conserved 
genes between human and murine embryonic stem cells ( Wei et al., 2005). These 
data indicate that, depending on the biological context; the animal model can be 
closer or more deviant from the clinical situation. Obviously, the type of analysis 
determines the degree of interspecies overlap as well. The number of potential target 
genes in the invasion front compartments could easily increase to 50% and more 
(Table 2, lowest panel) if human up-regulated genes only had to be present (but not 
necessarily up regulated in the respective murine compartments). It is, however, 
unlikely that such target genes would indeed represent the targeted biological 
pathway in the animal model.   
5.1.2 Tumor model 
Only 1.6% of exclusively up-regulated genes were overlapping among the tumor 
compartments, which obviously has a severe impact on the mechanisms in the 
invasion front. No overlapping GO-terms between the tumor compartments were 
detected.  The murine tumor displayed more features of uniqueness than its human 
counterpart (51 vs. 11 GO terms, data not shown). Most of these terms were 
associated with primary metabolism.  In contrast to secondary metabolism, which 
produces and breaks down compounds that are essential for the whole organism, 
primary metabolism contains all pathways necessary to keep the cell alive. While the 
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liver is known to be the classical site of secondary metabolism (see above), it is more 
difficult to explain why only the murine tumor compartment displays such a huge 
number of primary metabolism terms. Primary metabolism is also defined as normal 
anabolic and catabolic processes that result in assimilation, respiration, transport, 
and differentiation and which directly function in the processes of growth and 
development. A closer look at the sub-terms reveals that several belong to protein 
biosynthesis so that it can be predicted that the tumor compartment in the murine 
model is mainly occupied with maintaining its primary functions represented e.g. 
protein biosynthesis. Histologically, both examined cancer types were 
adenocarcinomas of colorectal origin. However, the murine tumor is a lowly 
differentiated to undifferentiated carcinoma whereas the human specimens manifest 
moderate to low differentiation. These histological differences may partly explain low 
overlap of tumor compartments. 
5.1.3 Misleading histology 
Another reason for limited single-gene overlaps in the invasion front compartments 
may be due to the fact that mechanisms involved in invasion do not appear to 
respect boundaries as estimated by standard histopathologic observation; the most 
striking observation was the relatively high degree of overlap between human liver 
invasion and murine tumor invasion which was 6.25% (versus 2.8% with murine liver 
invasion) on the single-gene level and 16.5% (vs. 0% for murine liver invasion) on the 
pattern level. Despite different tissue of origin, typical invasion front patterns such as 
“cell adhesion”, “extracellular matrix”, “organ development” and “antigen 
presentation” were present in human liver invasion and murine tumor invasion, which 
indicate that these compartments may be functionally similar. In addition, liver 
compartments displayed strong immune response patterns that may be a part of a 
host counterattack against the invading tumor. Liver immune response consisted 
mainly of innate immune response whereas invasion-related immune response was 
characterized by acquired immune response. 
From these data one can conclude that when mining for invasion target genes, one 
should consider the invasion front as a whole and even take tissue further away from 
the invasion front like the liver compartments into consideration.  
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5.1.4 Functional redundancy 
A fourth reason for the limited overlap of target genes is the redundancy of gene 
regulation within biological processes. Neoplastic processes that are targeted by 
drugs include proliferation, apoptosis, invasion and several more. These processes 
are on the descriptive level of pattern families or patterns. Many animal models for 
target gene determination or validation are chosen according to whether they exhibit 
these pattern-like functions. As data shows, the degree of similarity on the pattern 
family level between clinical samples and the animal model can be fairly high, but it 
decreases dramatically with an increase of specificity of the underlying processes 
(single GO- terms) down to that low degree of overlap on the single-gene level.  The 
liver compartments, for example, displayed a high degree of similarity on the level of 
patterns families as the “secondary metabolism” family was composed of 15 core 
GO-terms which are over-represented in both species and only 8 species-specific 
core GO-terms (Figure 5, columns 1 and 2). In contrast, on the level of single GO 
terms including those with less than 10 genes (those which are usually closer to the 
small branches of the GO tree) the overlap was only 28%. Finally, overlap on the 
single-gene level (all genes) was only 16.7%, which corresponds to the degree of 
overlap of the genes underlying overlapping GO-terms (17.8 % for the “lipid 
metabolism” term (Table 3)).  In other words, although the liver compartments of both 
species apparently carry out typical liver functions related to secondary metabolism 
and even sub-terms like “lipid metabolism” are significantly over-represented in the 
liver of both species, only a minor portion of the actual underlying genes are identical.  
Due to reasons described above the situation is even more complicated for invasion 
front and tumor compartments. That ultimately means that targeted biological 
processes are by nature represented by a variety of perhaps similar, perhaps 
alternative or even redundant genes.  
The problem of functional redundancy can probably be circumvented if the animal 
model is chosen a priori to have the same molecular defect as the human counterpart 
tumor. A recent publication argues in favor of this approach. A good correlation of 
gene expression profiles for a mouse model of KRAS2-induced lung cancer and 
KRAS2-mutated human lung carcinoma was reported (Sweet-Cordero et al.,2005).  
It is notable that in that same study (Sweet-Cordero et al.,2005), the gene expression 
signature of KRAS2 activation was not identifiable by analysis of human tumors 
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alone, but only by integration of mouse and human data. This integration indicates 
that a murine model, in addition to displaying molecular similarity, could uncover 
patterns or pathways relevant to human cancer that are obscured in the human data. 
Similarly in the current study, only through interspecies gene expression profiling, 
high degree of unspecific immune response in the liver away from the invasion front 
was uncovered, which would probably not have gained attention if only one species 
would have been used.     
5.2 Gene expression profiles of host tissue at the invasive front of 
colorectal liver metastases 
The crucial importance of the host reaction on metastatic invasion has been 
increasingly recognized. The results from the analysis of expression profiles of host 
tissue at the invasive front present the first global analysis of differential gene 
expression with emphasis on gene regulation of the host without severe interference 
by tumor cells. The findings indicate that 1) a xenograft model of colorectal tumor 
cells of human origin growing in the liver of nude mice can be reliably and repeatedly 
used for this purpose, 2) the patterns of gene expression in the host part of the 
invasion front are characterized by dramatically increased cellular communication 
and deposition of ECM and at the same time dramatically decreased metabolic 
functions and 3) activation and probably migration or proliferation of HSC in the 
invasive front are at least partly responsible for the observed phenomena. 
The difficulty to discriminate between desired and undesired cells upon 
microdissection of a histologic specimen is a common problem in the field of global 
molecular analysis of tissues (Maitra et al., 2001). Ways to solve this problem are 
either the performance of very time consuming and difficult microdissection 
procedures on the single cell level or extensive morphological validation of over-
expressed genes following microarray analysis. This problem can be circumvented 
by the xenograft model which allows successful hybridization of the desired host 
tissue of murine origin on Affymetrix mouse microarrays while any contaminations by 
invading tumor cells of human origin will hybridize to a dramatically lower extent on 
this murine chip. In addition, to eliminate any residual signals resulting from cross 
hybridizing human transcripts, all cross hybridizing genes were deleted prior to data 
analysis. Fortunately, this fraction comprises only 15.3 % of all genes that remain 
Discussion  
 96
after data tailoring such that the introduced bias might be tolerable at least for gross 
analysis of gene expression.  
The biological processes in the invasive front of liver metastases have not been 
systematically examined before. An unbiased, non hypothesis driven examination of 
the differences in global and single gene expression patterns between the host part 
of the invasion front and unaffected liver tissue lead to groups of up-regulated and 
down-regulated genes. The GO distribution of these groups was compared to the 
distribution of a reference group comprising all genes that are present either in the 
invasion front or the unaffected liver tissue. 
Genes of the ECM were found to be most strikingly up regulated in the invasion front. 
In principle, this finding supports earlier suggestions that remodelling of the ECM, 
which is confined to the immediate pericellular environment of the cell seems to be a 
necessary step in local invasion (Liotta et al., 1989& Werb et al., 1991). However, the 
dramatic up regulation was somewhat unexpected particularly because routine 
morphological HE staining did not suggest massive ECM deposition. Subsequent 
immunostaining against hepatocytes revealed that besides areas of close association 
of hepatocytes and tumor cells, regions with a narrow cell poor gap between these 
two populations exist where ECM seems to be deposited. Such a deposition of 
fibrotic material has been reported in activated cultured myofibroblast (Ooi et al., 
1995) as well as for human metastases of colorectal origin where the formation of 
fibrotic capsules surrounding the tumor has been found in 20% within a group of 69 
examined cases (Lunevicius et al., 2001). On one hand, such ECM deposition may 
have an anti-tumor defensive function as indicated by the better prognosis if capsules 
have formed around colorectal liver metastases (Lunevicius et al., 2001) or the fact 
that less liver metastases are formed in cirrhotic livers (Pereira-Lima et al., 2003). On 
the other hand, ECM deposition seems to provide proinvasive signals (De Wever et 
al., 2002& 2003). Tenascin that is upregulated in the invasion front in the current 
model provides proinvasive signals to colon cancer cells (De Wever et al., 2004). 
Finally, the differentially up-regulated ECM molecules fibronectin and collagen IV 
have proangiogenic properties (Jain et al., 2003). 
The most likely candidate cells responsible for ECM production are HSC that are 
transformed into myofibroblasts upon activation by profibrogenic signals (De Wever 
et al., 2002& 2003). Their role in hepatic fibrosis has been described to a significant 
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extent and HSC have been described to be the major source of ECM in the liver 
(Armendariz-Borunda et al., 1989 & Schmitt-Graff et al., 1991).  
Five HSC genes belong to the class of actin genes or actin-binding genes, namely 
actinin α (1), the tropomyosins 1 and 4, transgelin (SM22α) and α-smooth muscle 
actin (α-SMA). α-SMA is a typical and widely used HSC activation marker, which 
seems to be expressed if HSC acquire contractile and refractile features typically 
described during the development of liver fibrosis (Schmitt-Graff et al., 1991). 
Dramatic up regulation of α-SMA and transgelin were confirmed the in the invasion 
front by qPCR and immunohistochemistry. Similar results of HSC specific 
immunoreactivity have been found for human specimen (Lunevicius et al., 2001& Ooi 
et al., 1997). 
The tropomyosins stabilize actin fibers and the α-actinins are actin-cross linking 
proteins that are responsible for the formation of contractile bundles. They are 
concentrated in stress fibres, which they hold in contact to the plasma membrane. 
Transgelin is an actin cross-linking protein as well but is rather responsible for the 
construction of actin networks (gelling). The up regulation of these cytoskeletal genes 
is paralleled by the significant overrepresentation of cytoskeleton related GO terms 
such as “ structural molecule activity”, “cytoskeleton” and “actin cytoskeleton” (Table 
5). The up regulation of cytoskeletal genes in the invasion front and their activation 
status in HSC most likely results from the required modulations of cell shape, motility 
and adhesion. In addition, α-actinin and tropomyosin dependent reorganisation of the 
actin cytoskeleton has been reported to occur upon retinol treatment of HSC 
(Mermelstein et al., 2001). In our model, one additional protein involved in retinoid 
metabolism, retinol binding protein 1 (cRBP-1) was found to be up-regulated as well. 
HSC are the main cell type responsible for retinol metabolism and storage in the liver 
(Hendriks et al., 1987). In addition to their already described roles the up-regulated 
genes α-SMA, RBP-1 and transgelin are myoblastic differentiation genes. They are 
supplemented by galectin-1 whose gene product is a member of the family of beta-
galactoside-binding proteins implicated in modulating cell-cell and cell-matrix 
interactions up-regulated in the invasion front. Interestingly, these HSC differentiation 
genes are paralleled by significant overrepresentation of the GO term 
“morphogenesis” which is the major sub term of “cell differentiation”. 
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The further analysis of the GO distribution of genes with overrepresentation in the 
invasion front reveals several more interesting patterns which are however less 
specific for HSC. 
It is obvious that deposition of ECM requires repeated cycles of detachment and 
attachment to the surrounding structures by the involved cells and that such an area 
of intensive cellular interplay will require a lot of cellular communication. These 
phenomena are reflected in this xenograft model by a very prominent 
overrepresentation of the GO terms “cell communication”, “cell adhesion” and “cell 
adhesion molecule activity” in the invasive front. Further localisation and more 
mechanistic studies are however required to pinpoint the specific roles of host cell 
adhesion molecules in this model e.g. proangiogenic integrins on endothelial cells 
(Jain et al., 2003), cadherins like N-cadherin on myofibroblasts for interaction with 
and paving the way for cancer cells (De Wever et al., 2003&2004) or adhesion 
molecules for the initial attachment of circulating cancer cells (Zetter et al., 1993, 
Cavallaro et al., 1996 & Brand et al., 2001). 
Host cells in the invasion front are apparently intensively responding to the external 
stimuli initiated by tumor invasion since the GO terms “response to external stimulus” 
and “response to biotic stimulus” are over represented. Interestingly, immune 
response genes seem to account for most of these up-regulated transcripts. The high 
level of significance of MHC II restricted antigen processing genes argues for 
macrophages, most likely the resident Kupffer cells as one main source of immune 
response genes. Several other significant GO terms such as “chemotaxis” and 
“inflammatory response”, or “chemokine receptor activity” indicate paracrine effects 
leading to the recruiting of circulating cells, perhaps neutrophils to the invasion front. 
Macrophages (Lin et al., 2001), neutrophilic granulocytes (Obermueller et al., 2004) 
and mast cells (DeClerck et al., 2004) have been shown to exhibit tumor-supporting 
effects. On the other hand, an inflammatory immune response is a well known anti-
tumor host reaction. Therefore, it will be very interesting to evaluate under which 
circumstances the described prevention of physical contact between inflammatory 
cells and cancer cells by myofibroblasts and their surrounding ECM (Lieubeau et al., 
1999) will be beneficial or not. 
The significantly over represented terms “cell growth” and “cell proliferation” indicate 
that the cells of the invasion front are more active than unaffected liver with respect to 
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cell division. On one hand, this fits to the observed differences in the cellular 
composition of these two areas and particularly to morphological data, which 
indicates a decrease of hepatocytes and an increase of HSC in the invasion front. On 
the other hand, at least cancer cells in the invasion front can be higher (Dissanayake 
et al., 2003) as well as lower (Jung et al., 2001) in proliferation than their counterparts 
in the inner parts of the tumor allowing them to concentrate on their specific roles in 
the process of invasion. This may hold true for some host cells as well but not for 
others (like endothelial cells). Further studies like single cell microdissection and 
protein localisation are required to determine the responsible cell populations. 
The examination of the genes and GO terms which are down-regulated in the 
invasion front as compared to the unaffected liver revealed a dramatic 
overrepresentation of metabolism related genes. Several of the major metabolic 
pathways seem to be impaired in the invasion front which is particularly interesting as 
not one single metabolic pathway was found to be increased in the invasion front. 
The most dramatically reduced GO term among the metabolic functions was 
“electron transport” represented by “oxidoreductase activity” which takes place in 
“mitochiondria”.  In addition, several GO terms representing typical hepatocellular 
functions e.g. “urea cycle” or “steroid biosynthesis” were found to be over 
represented among the genes down-regulated in the invasion front. These findings 
can be interpreted as indicators of severely impaired physiological functions mainly of 
hepatocytes upon confrontation with invading tumor cells. In addition, 
immunohistochemistry revealed that hepatocytes might be under-represented in 
number within the microdissected samples of the invasion front. 
In summary, the global genomic analysis of the host reaction of the liver tissue on 
tumor infiltration indicates dramatic changes of the cellular composition and 
activation status of the different types of parenchymal and non-parenchymal liver 
cells.  
5.3 Gene expression profiles of tumor cells in vitro, in vivo and at the 
invasion front of colorectal liver metastases 
Using a combination of microarrays and real time quantitative PCR fifteen genes 
have been identified to be up regulated at the invasion front compared to the inner 
parts of the tumor which might be invasion and metastasis associated. As a starting 
point for the evaluation of the cross talk of tumor cells and host cells regarding 
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angiogenesis in the invasion front, gene expression data was examined for genes 
involved in angiogenesis. Surprisngly one class of pro-angiogenic molecules, the 
ELR+CXC chemokines were differentially regulated. All pro-angiogenic members of 
that family including potent pro-angiogenic CXCL8 (IL-8) were up regulated in the 
tumor cells of the invasion front as compared to the tumor core. Moreover, angiostatic 
CXC chemokines like CXCL9, 10, 11 do not seem to be expressed by the tumor cells 
or at least not at a higher level in the invasion front (data not shown). The possible 
role of CXC chemokines in colorectal liver metastasis will be discussed in the 
following sections. β-catenin which appeared to be the most interesting candidate 
gene was chosen for further studies. These results will be discussed in section 4.3.2.  
5.3.1 CXC Chemokines 
A. Role of chemokines and their receptors in tumor biology 
Although chemokines were initially characterized as attractants of leukocytes, it is 
now widely recognized that any cell type can express chemokines and chemokine 
receptors. In particular, their expression by tumor cells has attracted much attention, 
and the prevailing hypothesis implicates chemokines as road signs for tumor cell 
invasion and metastasis. However, chemokines appear to function more than as 
attractants, and increasing evidence indicates that interactions between chemokines 
and their receptors are important in virtually every step of tumor development, 
including tumor growth, progression, and metastasis, as reviewed by Tanaka et al., 
2005. Emerging evidence indicates that chemokines are directly involved in the 
transformation, survival and growth of tumor cells. For instance, several chemokines, 
including CXCL1/ Groα/MGSAα and CXCL8/IL-8, bind not only to their natural 
receptor, CXCR2, but also to the G-protein-coupled receptors (Tanaka et al., 2005). 
 
B. Chemokines enhance invasion 
Invasion is in fact a physiological function that leukocytes constantly execute in 
inflammation. The direction of leukocyte migration is towards increasing chemokine 
concentrations. Chemokines, while attracting leukocytes, often activate the 
production of cytoskeletal motor proteins, secreted proteinases and glycanases and 
the expression of adhesion molecules, including mucins, selectins, integrins and 
immunoglobulin family receptors. Whereas chemokine actions have been mainly 
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studied in immune responses, these activities have also been observed in specific 
tumor models. For instance, prostate tumor cells, responding to IL-8/CXCL8 through 
CXCR2 are more invasive in vitro (Reiland et al., 1999) and chemokines induce 
migrational responses (chemotaxis and cytoskeletal changes) in various human 
breast carcinoma cell lines (Youngs et al., 1997). In vivo, the invasive phenotype may 
be assisted by tumor-derived chemokines. Indeed, expression of IL -8/CXCL8 mRNA 
in ovarium carcinoma is correlated with histological grading (Davidson et al., 2002). 
In many models, xenografting with chemokine expressing cancer cells has been used 
to show chemokine action (i.e. tumor infiltration of leukocytes and proteinase 
induction) (Melani et al., 1995). It needs to be noticed that in most of these settings a 
strong immune response is elicited and thus the tumor may eventually grow, but often 
is rejected by the workings of the hosts immune response (vide infra). 
 
C. Chemokines provide paracrine growth advantages via angiogenesis 
Angiogenesis has been well studied in the biology of organ development, tissue 
repair and cancer growth and invasion. Vessel growth, relevant for cancer, varies 
widely (e.g. blood and lymph vessels) and is governed by many factors that stimulate 
(e.g. angiogenesis by vascular endothelial growth factors) or dampen (e.g. 
angiostatin) proliferation of the various types of endothelial cells (Folkman, 1995).  
After local growth and crossing tissue barriers, the tumor cells may enter blood or 
lymph vessels. This forms the first phase of tumor cell entry during the process of 
metastasis. In many ex vivo studies, the expression of chemokines has been 
associated with higher clinical tumor staging. Along this line, studies are available on 
IL- 8/CXCL8 in cutaneous melanoma, malignant melanoma, ovarian carcinoma, non-
Hodgkin lymphoma, breast carcinoma and lung cancer (Opdenaakker et al., 2004). 
Whether the process of vessel entry is determined by enzyme induction, by the 
process of angiogenesis, by both or by still other mechanisms must await further 
experimentation, e.g. by using specific knockout models or by specifically blocking 
proteinases or chemokines with monoclonal antibodies. 
Because chemokines and chemokine receptors are important in tumor progression 
and metastasis, disrupting these interactions may prove to be a useful approach for 
treating cancers. However, given the complex nature of carcinogenesis and 
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metastasis formation, let alone the heterogeneity of different cancers, it is not likely 
that any single inhibitor or functional modulator of chemokines or chemokine 
receptors will become a ‘cure’ for cancer. It is more probable that, when used in 
conjunction with other therapeutic regimens, newly discovered chemokine- or 
chemokine-receptor-based agents will contribute significantly to the control of tumor 
cell invasion and metastasis. Such an approach may lead to many cancers becoming 
dormant and clinically manageable. An increased understanding of the mode of 
action of chemokines on tumor cells and their microenvironment will help us meet 
this goal. 
 
5.3.2 Activation of the β-catenin promoter in the invasion front of 
colorectal liver metastases 
Activation of the β -catenin promoter finding supports earlier assumptions originating 
from promoter studies (Nollet et al.,1996 & Li et al.,2004) and observations of 
elevated mRNA levels (El-Bahrawy et al., 2001& Mann et al., 1999, Ebert et al., 
2002, Cui et al., 2001 & Saito et al., 2002) in tumors, suggesting that β-catenin may 
be regulated on the transcriptional level in addition to the well studied post-
translational regulation. It should however be mentioned that in our model micro 
environmental changes, which are most likely not genetically fixed, are probably 
responsible for promoter activation. It has to be determined whether this holds true 
for the reported elevated β-catenin mRNA in tumor tissue resulting from the 
comparison with normal tissue. 
In LS174T xenograft model the most prominent promoter activity was seen in cells at 
the invasion front. Some increase was seen between the in vitro and the in vivo 
situation. Therefore it can be assumed that the interaction between invading tumor 
cells and host cells is responsible for promoter activation but which signals are 
involved will be subject of future investigation.  
Since increased promoter activity is converted into increased mRNA levels and finally 
into increased protein content, once can assume that transcriptional regulation plays 
a dominant role for protein content at least in LS174T xenograft model. Increased 
protein levels at the invasion front of colorectal liver metastases have occasionally 
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been reported (Brabletz et al., 2001) but seem to be inconsistent and not generally 
occurring.  
Among the regulating proteins involved in activation of the β-catenin promoter, β-
catenin itself might play a role in this model. Since LS174T cell line is characterized 
by high levels of β-catenin protein even in cell culture, and a TCF/LEF site has 
recently been detected in the β-catenin promoter (Li et al.,2004) a positive feed back 
loop between increased β-catenin protein and increased transcription of its gene is 
likely to occur. This hypothesis is supported by the fact that particularly high mRNA 
levels of β-catenin in desmoid tumors (Saito et al., 2002) and in gastric carcinomas 
(Ebert et al., 2002) were correlated to high levels of mutated β-catenin. It will be 
interesting to examine whether increased promoter activity is associated with the 
subset of colorectal cancers harbouring oncogenic β-catenin mutations. If this holds 
true, an a priori increased rate of β-catenin transcription might facilitate the binding of 
other transcription factors that are specific for the in vivo situation, particularly at the 
invasion front. 
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Conclusions 
The overall aim of this thesis is to provide candidate genes for small molecule 
inhibitors and gene therapeutics for the treatment of colorectal liver metastases with 
special emphasis on the invasion front because this area is only poorly described 
although it is of crucial relevance for metastatic invasion. Initial experiments involved 
the microdissection and gene expression profiles of three to four distinct areas of the 
invasion front and the surrounding tissue namely unaffected liver, liver invasion, 
tumor invasion and tumor further away from the invasion front towards a more 
general understanding of the regulatory processes during invasion. 
Differential gene expression was examined in three model systems: A syngeneic 
mouse model (CT26/Balb/C mouse, a xenograft mouse model (LS174/nude mouse) 
and several clinical specimens. Initial results regarding these three different models 
yielded similar gene expression patterns in the invasion front of colorectal liver 
metastases. For candidate gene evaluation, the xenograft mouse model was used: 
This model is a human tumor growing in the liver of mice has the advantage that one 
can discriminate between host derived and tumor cell derived genes. This helped to 
confirm differentially regulated genes from global gene expression studies by real 
time PCR using species-specific primers. 
Use of laser captured microdissection and xenograft mouse model enabled to 
perform mRNA analysis between liver, liver invasion tumor and tumor invasion front.  
Histology and gene expression patterns are valuable to understand cancer-relevant 
processes and to judge on the suitability of animal models. However, due to inherent 
species differences and functional redundancy the number of actual target genes that 
are similarly regulated in both the clinical situation and the animal model has to be 
determined individually in standard grafted models. Invasion relevant genes in a 
murine model may not be relevant in exactly the same compartment and in exactly 
the same tumor entity (but probably in several others) in the human situation. 
The results from the xenograft model of colorectal liver metastasis indicate that the 
tumor host interface is characterized by extensive cellular communication 
accompanied by remodelling of the extracellular matrix. The predominant cell type in 
that area which is probably responsible for many of the observed processes was 
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found to be activated HSC. Further experimentation will address two important 
remaining issues:  
1.  The discrimination between truly up-regulated genes and those genes whose 
increased transcript detection is rather due to an increase of the respective 
cellular subpopulation?  
2.  The precise cellular origin of up-regulated transcripts.Studies on transcriptional 
profiles of cells grown in vitro with profiles of orthotopically implanted tumors 
show an intricate molecular interplay between the tumor and host 
microenvironments that likely regulates important aspects of tumor biology. 
Concerns regarding the potential confounding effect of mouse tissue when 
profiling xenograft tumors using human arrays to determine (human) cancer 
cell expression patterns are alleviated by the findings of tissue-specific and 
cytokine-induced responses of cells to the microenvironment. We may expect 
that different cell lines respond differently to the in vivo microenvironment. 
Consequently, xenograft tumor profiling studies on a larger scale may be 
highly informative with respect to the extent to which these cell lines when 
grown in vivo may exhibit different properties compared with their in vitro 
growth. However, cell lines grown in vitro remain a powerful model for studying 
cancer; this study indicates that novel therapeutic targets or biomarkers may 
be found by superseding in vitro models and looking initially at in vivo models.  
Further experimentation on CXC chemokines will answer the following questions 
1. Histomorphologic angiogenesis picture of the invasion front in our model. 
2. Role of putative pro-angiogenic CXC cytokines during neo-angiogenesis. 
3.  Whether CXC cytokines are the main soluble molecules secreted by tumor  
  cells during early angiogenesis? 
Further experiments on β-catenin activation will solve two important questions 
Generality and clinical importance of transcriptional activation of the β-catenin 
promoter. 
Mechanism of β-catenin promoter activation in vivo and particularly in the invasion 
front  
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